Paul Dorian

Q: What Schools Are Affiliated With Paul Dorian

Paul Dorian is affiliated with the following schools: McGill University, McMaster University, Dalhousie University, University of Toronto

Paul Dorian's AcademicInfluence.com Rankings

Paul Dorian

Medical

#593

World Rank

#797

Historical Rank

Cardiology

#56

World Rank

#57

Historical Rank

medical Degrees

Paul Dorian

Philosophy

#5552

World Rank

#8385

Historical Rank

Logic

#2809

World Rank

#3859

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Paul Dorian's Degrees

PhD Cardiology McGill University

Why Is Paul Dorian Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Paul Dorian is a Canadian physician. He is a professor of pharmacology and director of the Division of Cardiology at the University of Toronto. His primary research focus is the clinical pharmacology of antiarrhythmic drugs.

(See a Problem?)

Paul Dorian's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. (2000) (1564)
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. (2004) (1434)
Rhythm control versus rate control for atrial fibrillation and heart failure. (2008) (1406)
Atrial fibrillation in patients with cryptogenic stroke. (2014) (1018)
Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. (2006) (666)
Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. (2007) (650)
Amiodarone to Prevent Recurrence of Atrial Fibrillation (2000) (600)
The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. (2000) (593)
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. (2012) (522)
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. (2006) (452)
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. (2000) (419)
2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. (2014) (417)
Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. (2002) (396)
Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation (2018) (377)
Dronedarone in high-risk permanent atrial fibrillation. (2011) (368)
Quality of life in the Canadian Implantable Defibrillator Study (CIDS). (2002) (362)
New-Onset Atrial Fibrillation: Sex Differences in Presentation, Treatment, and Outcome (2001) (356)
Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. (2005) (341)
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias (2014) (333)
Development and Validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in Patients With Atrial Fibrillation (2011) (302)
Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. (2006) (249)
Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. (2002) (245)
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. (2012) (241)
Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database. (2010) (237)
Home use of automated external defibrillators for sudden cardiac arrest. (2008) (231)
The relationship between successful defibrillation and delivered energy in open-chest dogs: reappraisal of the "defibrillation threshold" concept. (1987) (229)
Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a meta-analysis. (2003) (219)
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. (2016) (212)
A trial of an impedance threshold device in out-of-hospital cardiac arrest. (2011) (211)
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. (2016) (211)
Elevated Depression Symptoms Predict Long-Term Cardiovascular Mortality in Patients With Atrial Fibrillation and Heart Failure (2009) (208)
Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators. (1999) (203)
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. (2014) (201)
The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure. (2013) (195)
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial (2012) (195)
Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. (1999) (194)
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation. (2020) (188)
Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation☆ (2002) (183)
Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial (2009) (179)
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. (2013) (178)
Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. (2000) (174)
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. (2018) (171)
Effect of Amiodarone and Sotalol on Ventricular Defibrillation Threshold: The Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Trial (2006) (169)
Long-Term Comparison of the Implantable Cardioverter Defibrillator Versus Amiodarone: Eleven-Year Follow-Up of a Subset of Patients in the Canadian Implantable Defibrillator Study (CIDS) (2004) (168)
Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. (2006) (165)
Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. (2007) (164)
Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). (2011) (161)
Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators. (1993) (160)
An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial. (1999) (159)
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. (2007) (158)
Validation of a New Simple Scale to Measure Symptoms in Atrial Fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale (2009) (155)
Predictors of Short-Term Complications After Implantable Cardioverter-Defibrillator Replacement: Results From the Ontario ICD Database (2011) (149)
Mechanisms Underlying the Lack of Effect of Implantable Cardioverter-Defibrillator Therapy on Mortality in High-Risk Patients With Recent Myocardial Infarction: Insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT) (2010) (148)
Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures. (2014) (148)
Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation: Results From the Resynchronization for Ambulatory Heart Failure Trial (RAFT) (2012) (146)
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. (2011) (144)
Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements. (1986) (144)
Is electrical storm in ICD patients the sign of a dying heart? Outcome of patients with clusters of ventricular tachyarrhythmias. (2000) (143)
Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke: Results From the EMBRACE Trial (2015) (143)
Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. (1995) (143)
Placebo-Controlled, Randomized Clinical Trial of Azimilide for Prevention of Ventricular Tachyarrhythmias in Patients With an Implantable Cardioverter Defibrillator (2004) (135)
Sex Differences in Implantable Cardioverter-Defibrillator Outcomes: Findings From a Prospective Defibrillator Database (2012) (131)
Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. (2010) (131)
Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group. (1996) (129)
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management. (2011) (127)
Cardiac Resynchronization Therapy in Patients With Heart Failure and a QRS Complex <120 Milliseconds: The Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) Trial (2013) (126)
Out-of-hospital cardiac arrest rectilinear biphasic to monophasic damped sine defibrillation waveforms with advanced life support intervention trial (ORBIT). (2005) (126)
Trends in Short- and Long-Term Survival Among Out-of-Hospital Cardiac Arrest Patients Alive at Hospital Arrival (2014) (123)
Prevention of Arrhythmia Device Infection Trial: The PADIT Trial. (2018) (123)
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. (2016) (123)
Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa) (2013) (123)
Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. (1999) (121)
Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry. (2014) (121)
Sudden Cardiac Arrest during Participation in Competitive Sports (2017) (120)
Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFα (2015) (119)
The Effect of Vernakalant (RSD1235), an Investigational Antiarrhythmic Agent, on Atrial Electrophysiology in Humans (2007) (114)
The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation. (2010) (111)
A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. (2003) (109)
Cardiac electrophysiological consequences of neuromuscular incapacitating device discharges. (2006) (109)
Quality of life in patients with silent atrial fibrillation (2001) (109)
The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications. (2015) (108)
Psychopathology in Patients with ICDs over Time: Results of a Prospective Study (2010) (104)
Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. (2004) (102)
Out-of-hospital cardiac arrest frequency and survival: evidence for temporal variability. (2010) (101)
Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation. (2017) (100)
Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options (2011) (98)
Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure. (2013) (98)
Effects of encainide and its metabolites on energy requirements for defibrillation. (1986) (98)
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation (2014) (96)
Structure of an Internal Bore and Dissipating Gravity Current as Revealed by Raman Lidar (1991) (95)
DL and D Sotalol Decrease Defibrillation Energy Requirements (1989) (95)
Improvement in Cheyne-Stokes respiration following cardiac resynchronisation therapy (2005) (93)
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. (2009) (93)
Survival After Implantable Cardioverter-Defibrillator Implantation in the Elderly (2013) (92)
A mesoscale gravity wave event observed during CCOPE. III - Wave environment and probable source mechanisms (1988) (91)
Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients: Does Age Matter? An Analysis of Pooled Data From 5 Clinical Trials (2015) (90)
Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy. (2012) (90)
Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial. (2014) (89)
Improving SVT Discrimination in Single‐Chamber ICDs: A New Electrogram Morphology‐Based Algorithm (2006) (89)
Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. (2014) (88)
Effect of pacing mode on health-related quality of life in the Canadian Trial of Physiologic Pacing. (2003) (87)
Gender differences and quality of life in atrial fibrillation: the mediating role of depression. (2006) (86)
A population-based description of atrial fibrillation in the emergency department, 2002 to 2010. (2013) (86)
The 2002/3 Canadian Cardiovascular Society consensus guideline update for the diagnosis and management of heart failure. (2003) (85)
Management of cardiac arrest in pregnancy: a systematic review. (2011) (84)
A Randomized Controlled Trial of Cognitive Behavior Therapy Tailored to Psychological Adaptation to an Implantable Cardioverter Defibrillator (2011) (84)
Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation. (2014) (83)
A randomized trial comparing monophasic and biphasic waveform shocks for external cardioversion of atrial fibrillation. (2004) (83)
Identifying Patients With Atrial Fibrillation in Administrative Data. (2016) (82)
The Canadian Registry of Atrial Fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation. (1998) (82)
A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale. (2006) (80)
Improving Temporal Trends in Survival and Neurological Outcomes After Out-of-Hospital Cardiac Arrest (2018) (80)
Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter. (2004) (80)
Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model. (2008) (79)
Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis (2008) (77)
Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful? (2013) (77)
Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials. (2014) (77)
Assessment of the cardiac patient for fitness to drive: drive subgroup executive summary. (2004) (76)
Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia (2010) (75)
The association of left atrial size and occurrence of atrial fibrillation: A prospective cohort study from the Canadian Registry of Atrial Fibrillation (2004) (75)
Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada. (2005) (75)
Effect of sotalol on ventricular fibrillation and defibrillation in humans. (1993) (75)
Risk Factors for Infections Involving Cardiac Implanted Electronic Devices. (2019) (74)
Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines. (2017) (74)
Thrombogenicity of radiofrequency ablation procedures: what factors influence thrombin generation? (2001) (73)
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: etiology and initial investigations. (2011) (71)
n-3 Polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial cardiomyopathy. (2010) (70)
Five-year experience with implantable defibrillators in children. (1996) (69)
Psychological Correlates of Quality of Life in Atrial Fibrillation (2006) (69)
Autonomie Correlates of Antidepressant Treatment Using Heart-Rate Variability Analysis (1998) (67)
Rapid induction of therapeutic hypothermia using convective-immersion surface cooling: safety, efficacy and outcomes. (2010) (66)
An overview of the management of electrical storm. (1997) (63)
Atrial dyssynchrony syndrome: an overlooked phenomenon and a potential cause of ‘diastolic’ heart failure (2012) (62)
The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group. (2004) (62)
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction (2005) (59)
Cardiac arrest survival did not increase in the Resuscitation Outcomes Consortium after implementation of the 2005 AHA CPR and ECC guidelines. (2011) (59)
Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis. (2017) (59)
Resuscitation Outcomes Consortium-Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): Rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial. (2014) (59)
Nocturnal and daytime panic attacks—comparison of sleep architecture, heart rate variability, and response to sodium lactate challenge (1999) (59)
The defibrillator in acute myocardial infarction trial (DINAMIT): study protocol. (2000) (59)
Antiarrhythmic Action ofβ-Blockers: Potential Mechanisms (2005) (59)
Role of KATP Channels in the Maintenance of Ventricular Fibrillation in Cardiomyopathic Human Hearts (2011) (58)
Randomized cluster crossover trials for reliable, efficient, comparative effectiveness testing: design of the Prevention of Arrhythmia Device Infection Trial (PADIT). (2013) (57)
Electrocardiograms in Low-Risk Patients Undergoing an Annual Health Examination (2017) (56)
Randomized controlled comparison of antitachycardia pacing algorithms for termination of ventricular tachycardia. (1993) (56)
Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life. (2003) (55)
Does this patient with palpitations have a cardiac arrhythmia? (2009) (55)
Resuscitation Outcomes Consortium (ROC) PRIMED cardiac arrest trial methods part 1: rationale and methodology for the impedance threshold device (ITD) protocol. (2008) (55)
Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario. (2019) (54)
Effects of Thrombolytic Therapy Administered 6 to 24 Hours After Myocardial Infarction on the Signal‐Averaged ECG: Results of a Multicenter Randomized Trial (1994) (54)
Factors associated with 90-day death after emergency department discharge for atrial fibrillation. (2013) (53)
Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group. (1992) (53)
Epinephrine and vasopressin during cardiopulmonary resuscitation. (2005) (53)
d‐Sotalol Decreases Defibrillation Energy Requirements in Humans: (1996) (53)
The acute treatment of maternal supraventricular tachycardias during pregnancy: a review of the literature. (2011) (53)
A Mesoscale Gravity Wave Event Observed during CCOPE. Part II: Interactions between Mesoscale Convective Systems and the Antecedent Waves (1988) (52)
Outcomes for Emergency Department Patients With Recent‐Onset Atrial Fibrillation and Flutter Treated in Canadian Hospitals (2017) (52)
Effects of Chronic Gap Junction Conduction–Enhancing Antiarrhythmic Peptide GAP-134 Administration on Experimental Atrial Fibrillation in Dogs (2009) (52)
Inappropriate therapy from atrial fibrillation and sinus tachycardia in automated implantable cardioverter defibrillators. (2000) (51)
Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder. (1997) (51)
Prognostic differences between atrial fibrillation and atrial flutter. (2004) (51)
Is Inappropriate Implantable Defibrillator Shock Therapy Predictable? (2003) (50)
Digoxin-cyclosporine interaction: severe digitalis toxicity after cyclosporine treatment. (1988) (49)
Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators (2015) (49)
Wide variability in drug use in out-of-hospital cardiac arrest: a report from the resuscitation outcomes consortium. (2012) (49)
Biphasic versus Monophasic Cardioversion in Shock‐Resistant Atrial Fibrillation: (2003) (48)
Effect of quinidine and bretylium on defibrillation energy requirements. (1986) (48)
Defibrillation Testing at the Time of ICD Insertion: An Analysis From the Ontario ICD Registry (2010) (48)
Health-Related Quality of Life in Patients With Atrial Fibrillation Treated With Rhythm Control Versus Rate Control: Insights From a Prospective International Registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation RECORD-AF) (2014) (48)
Tedisamil increases coherence during ventricular fibrillation and decreases defibrillation energy requirements. (1997) (47)
Feasibility of Implantable Cardioverter Defibrillator Use in Elderly Patients: (2004) (47)
The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization. (2014) (47)
Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview. (2000) (47)
Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry (2019) (46)
Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation (2016) (46)
Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation. (2003) (45)
Mexiletine as an Adjunctive Therapy to Amiodarone Reduces the Frequency of Ventricular Tachyarrhythmia Events in Patients With an Implantable Defibrillator (2013) (45)
Panic disorder and the heart: a cardiology perspective. (2000) (45)
Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model. (1991) (44)
The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. (2005) (44)
Canadian Registry of ICD Implant Testing Procedures (CREDIT): Current Practice, Risks, and Costs of Intraoperative Defibrillation Testing (2010) (44)
Cumulative experience of azimilide-associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database. (2006) (43)
Canine Model (2005) (42)
DOuble Sequential External Defibrillation for Refractory Ventricular Fibrillation: The DOSE VF Pilot Randomized Controlled Trial. (2020) (42)
Clinical Pharmacology of Dronedarone: Implications for the Therapy of Atrial Fibrillation (2010) (41)
Dantrolene Improves Survival After Ventricular Fibrillation by Mitigating Impaired Calcium Handling in Animal Models (2014) (41)
The burden of atrial fibrillation on the hospital sector in Canada. (2013) (40)
A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group. (1996) (40)
Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure. (2008) (40)
Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest (2020) (38)
Improving Use of Targeted Temperature Management After Out-of-Hospital Cardiac Arrest: A Stepped Wedge Cluster Randomized Controlled Trial* (2015) (38)
Design and implementation of a population-based registry of Implantable Cardioverter Defibrillators (ICDs) in Ontario. (2008) (38)
Antiarrhythmic use from 1991 to 2007: insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II). (2010) (38)
The American Heart Association 2010 guidelines for the management of cardiac arrest in pregnancy: consensus recommendations on implementation strategies. (2011) (38)
Reversible "cardiomyopathy" after accidental adrenaline overdose. (1991) (38)
Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation (2012) (38)
The prevalence of obstructive sleep apnea in patients with atrial fibrillation (2018) (37)
Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke (2016) (37)
Is there acute tolerance to alcohol at steady state? (1985) (37)
A knowledge translation collaborative to improve the use of therapeutic hypothermia in post-cardiac arrest patients: protocol for a stepped wedge randomized trial (2011) (36)
Management of supraventricular tachycardia in the emergency department. (1997) (36)
Lithium-induced sinus node disease at therapeutic concentrations: linking lithium-induced blockade of sodium channels to impaired pacemaker activity. (2007) (36)
COVID-19–Myocarditis and Return to Play: Reflections and Recommendations From a Canadian Working Group (2020) (36)
Statin use and recurrence of atrial fibrillation after successful cardioversion. (2007) (35)
Guidelines for implantable cardioverter defibrillator follow-up in Canada: a consensus statement of the Canadian Working Group on Cardiac Pacing. (2003) (35)
Amitriptyline and ethanol: Pharmacokinetic and pharmacodynamic interaction (2004) (35)
Resolving Bipolar Electrogram Voltages During Atrial Fibrillation Using Omnipolar Mapping (2017) (35)
Treatment of tachyarrhythmias. (2001) (34)
A mesoscale gravity-wave event observed during CCOPE. IV: Stability analysis and doppler-derived wave vertical structure (1993) (34)
A randomized controlled feasibility trial comparing safety and effectiveness of prehospital pacing versus conventional treatment: ‘PrePACE’☆☆☆ (2007) (34)
Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators. (2010) (34)
Drug-induced QT prolongation and proarrhythmia: an inevitable link? (2007) (34)
Triazolam and ethanol interaction: Kinetic and dynamic consequences (1985) (33)
2004 Canadian Cardiovascular Society Consensus Conference: Atrial Fibrillation. (2005) (33)
Evaluation of zopiclone physical dependence liability in normal volunteers. (1983) (33)
CCS Consensus Conference 2003: Assessment of the cardiac patient for fitness to drive and fly - Executive summary (2004) (32)
Assessment of the cardiac patient for fitness to drive. (1992) (32)
Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence. (1997) (32)
The CHA 2 DS 2-VASc score identifies those patients with atrial fibrillation and a CHADS 2 score of 1 who are unlikely to benefit from oral anticoagulant therapy (2012) (31)
Limitations to antiarrhythmic drug use in patients with atrial fibrillation (2004) (31)
Cesium-induced torsades de pointes. (2002) (30)
Evaluating early repeat emergency department use in patients with atrial fibrillation: a population-based analysis. (2013) (30)
Atrial fibrillation care: challenges in clinical practice and educational needs assessment. (2011) (30)
Major Adverse Cardiovascular Events Associated With Postoperative Atrial Fibrillation After Noncardiac Surgery (2020) (30)
Quantitative assessment of brain microvascular and tissue oxygenation during cardiac arrest and resuscitation in pigs (2013) (30)
Long-term clinical outcomes and predictors for survivors of out-of-hospital cardiac arrest. (2017) (30)
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials (2017) (30)
Canadian Cardiovascular Society/Canadian Heart Rhythm Society Joint Position Statement on the Cardiovascular Screening of Competitive Athletes. (2019) (29)
Cardiac stimulation with high voltage discharge from stun guns (2008) (29)
Upstream therapies to prevent atrial fibrillation (2008) (29)
The Long-Term Use of Warfarin Among Atrial Fibrillation Patients Discharged From an Emergency Department With a Warfarin Prescription. (2015) (29)
The benefits of a simplified method for CPR training of medical professionals: a randomized controlled study. (2013) (29)
Anxiety Sensitivity Moderates Prognostic Importance of Rhythm-Control Versus Rate-Control Strategies in Patients With Atrial Fibrillation and Congestive Heart Failure: Insights From the Atrial Fibrillation and Congestive Heart Failure Trial (2012) (28)
Antiarrhythmic action of beta-blockers: potential mechanisms. (2005) (28)
Docosahexaenoic Acid, but Not Eicosapentaenoic Acid, Supplementation Reduces Vulnerability to Atrial Fibrillation (2012) (28)
Electrocardiographic interpretation skills of cardiology residents: are they competent? (2014) (28)
Defibrillation Energy Requirements Differ Between Anesthetic Agents (1989) (28)
Association of Left Ventricular Ejection Fraction with Mortality and Hospitalizations. (2020) (28)
Heterogeneity in Randomized Controlled Trials of Long Chain (Fish) Omega-3 Fatty Acids in Restenosis, Secondary Prevention and Ventricular Arrhythmias (2008) (28)
Azimilide Decreases Defibrillation Voltage Requirements and Increases Spatial Organization During Ventricular Fibrillation (1999) (27)
Nonpharmacological therapy for malignant ventricular arrhythmias: implantable defibrillator trials. (1996) (27)
Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial (2017) (27)
A novel pacing manoeuvre to diagnose atrial tachycardia. (2008) (27)
Influence of Ventriculoatrial Timing on Hemodynamics and Symptoms During Supraventricular Tachycardia (2009) (26)
Implantable cardioverter-defibrillator shock prevention does not reduce mortality: a systemic review. (2012) (26)
Targeted Temperature Management Processes and Outcomes After Out-of-Hospital Cardiac Arrest: An Observational Cohort Study* (2014) (26)
Sleep Apnea Increases the Risk of New Hospitalized Atrial Fibrillation: A Historical Cohort Study (2018) (25)
Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT). (2003) (25)
Blockade of IKs by HMR 1556 increases the reverse rate‐dependence of refractoriness prolongation by dofetilide in isolated rabbit ventricles (2006) (25)
Use of telemetry functions in the assessment of implanted antitachycardia device efficacy. (1992) (25)
Effect of global ischemia and reperfusion during ventricular fibrillation in myopathic human hearts. (2009) (25)
N-3 polyunsaturated fatty acid supplementation does not reduce vulnerability to atrial fibrillation in remodeling atria. (2012) (25)
Unexpected High Prevalence of Cardiovascular Disease Risk Factors and Psychiatric Disease Among Young People With Sudden Cardiac Arrest (2019) (24)
Order in disorder: effect of barium on ventricular fibrillation. (1996) (24)
Gap Junction Blockers Decrease Defibrillation Thresholds Without Changes in Ventricular Refractoriness in Isolated Rabbit Hearts (2001) (24)
Abstract 2860: Efficacy and Safety of Vernakalant Hydrochloride Injection for the Treatment of Atrial Fibrillation After Valvular or Coronary Artery Bypass Surgery (2007) (24)
Effects of Renal Artery Denervation on Ventricular Arrhythmias in a Postinfarct Model (2017) (24)
Update on advanced life support and resuscitation techniques (2005) (23)
The STOP‐BANG questionnaire shows an insufficient specificity for detecting obstructive sleep apnea in patients with atrial fibrillation (2018) (23)
Effects of rhythm regularization and rate control in improving left ventricular function in atrial fibrillation patients undergoing atrioventricular nodal ablation. (2001) (23)
Simultaneous right atrioventricular pacing: a novel model to study atrial remodeling and fibrillation in the setting of heart failure. (2008) (23)
Correlates of Therapeutic Response in Panic Disorder Presenting with Palpitations: Heart Rate Variability, Sleep, and Placebo Effect (2003) (23)
Implantable cardioverter‐defibrillators in heart failure patients with reduced ejection fraction and diabetes (2018) (22)
Prehospital sodium bicarbonate use could worsen long term survival with favorable neurological recovery among patients with out-of-hospital cardiac arrest. (2017) (21)
Influence of Hepatic Dysfunction on the Pharmacokinetics of Propafenone (1987) (21)
Slow delayed rectifier K+ current block by HMR 1556 increases dispersion of repolarization and promotes Torsades de Pointes in rabbit ventricles (2008) (21)
Standards for training in adult clinical cardiac electrophysiology. Canadian Cardiovascular Society Committee. (1996) (21)
QRS prolongation in patients with acute coronary syndromes. (2010) (20)
Predicting appropriate shocks in patients with heart failure: Patient level meta‐analysis from SCD‐HeFT and MADIT II (2016) (20)
Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. (2018) (20)
A double-blind placebo-controlled evaluation of the human electrophysiologic effects of zatebradine, a sinus node inhibitor. (1998) (20)
Azimilide reduces emergency department visits and hospitalizations in patients with an implantable cardioverter-defibrillator in a placebo-controlled clinical trial. (2008) (20)
Transcutaneous T Wave Shock: A Universal Method for Ventricular Fibrillation Induction (1997) (20)
Experimental studies of atrial fibrillation: a comparison of two pacing models. (2008) (19)
Recommendations for the Management of Dyslipidemia and the Prevention of Cardiovascular Disease: 2006 Update (2006) (19)
Incidence, outcomes and guideline compliance of out-of-hospital maternal cardiac arrest resuscitations: A population-based cohort study. (2018) (19)
Detecting paroxysmal atrial fibrillation after ischemic stroke and transient ischemic attack: if you don't look, you won't find. (2008) (19)
Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial (2017) (19)
The Postcardiac Arrest Consult Team: Impact on Hospital Care Processes for Out-of-Hospital Cardiac Arrest Patients* (2016) (19)
Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and Design. (2019) (19)
Challenge and Impact of Quinidine Access in Sudden Death Syndromes: A National Experience. (2019) (19)
Use of implantable cardioverter defibrillators after out-of-hospital cardiac arrest: a prospective follow-up study (2004) (19)
Gender Based Differences in Outcomes among Resuscitated Patients with Out-of-Hospital Cardiac Arrest. (2020) (18)
Population Trends in All‐Cause Mortality and Cause Specific–Death With Incident Atrial Fibrillation (2020) (18)
Relation of direct assessment of cardiac autonomic function with metaiodobenzylguanidine imaging to heart rate variability in diabetes mellitus. (1997) (18)
Efficacy and safety of dofetilide in the treatment of frequent ventricular tachyarrhythmias after amiodarone intolerance or failure. (2011) (18)
Strategies for reversing shock-resistant ventricular fibrillation (2003) (18)
Defibrillation Current and Impedance are Determinants of Defibrillation Energy Requirements (1988) (18)
Continuous Template Collection and Updating for Electrogram Morphology Discrimination in Implantable Cardioverter Defibrillators (2006) (17)
New approaches to atrial fibrillation management: treat the patient, not the ECG. (2010) (17)
Physician Stated Atrial Fibrillation Management in Light of Treatment Guidelines: Data From an International, Observational Prospective Survey (2010) (17)
Study of the Effects of Epinephrine on Cerebral Oxygenation and Metabolism During Cardiac Arrest and Resuscitation by Hyperspectral Near-Infrared Spectroscopy (2019) (17)
Factors associated with out-of-hospital cardiac arrest with pulseless electric activity: A population-based study. (2016) (17)
Living alone and cardiovascular disease outcomes (2019) (17)
Cardiac Resynchronization Therapy in Patients with Heart Failure and a QRS Complex <120 ms: the LESSER-EARTH Trial (2013) (17)
Rate control in atrial fibrillation. (2010) (16)
Temporal trends in sudden cardiac death in Ontario, Canada. (2019) (16)
Predictors and clinical outcomes of inpatient versus ambulatory management after an emergency department visit for atrial fibrillation: A population-based study. (2016) (16)
A Clinical Decision Instrument for 30-Day Death After an Emergency Department Visit for Atrial Fibrillation: The Atrial Fibrillation in the Emergency Room (AFTER) Study. (2015) (16)
When Pacemakers Fail: An Analysis of Clinical Presentation and Risk in 120 Patients with Failed Devices (1998) (16)
The Effects of Cardiac Transplantation and Cyclosporine Therapy on Digoxin Pharmacokinetics (1992) (16)
A randomized, double-blind, placebo-controlled trial assessing the efficacy of S66913 in patients with paroxysmal atrial fibrillation (2018) (16)
Canadian Cardiovascular Society Quality Indicators for Heart Failure. (2016) (16)
The Atrial Fibrillation Therapies after ER visit: Outpatient Care for Patients with Acute AF - The AFTER3 Study. (2015) (16)
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. (2013) (16)
Circadian variation of sustained ventricular tachycardia in patients subject to standard adrenergic blockade. (1997) (15)
Cerebral Hemodynamics and Metabolism During Cardiac Arrest and Cardiopulmonary Resuscitation Using Hyperspectral Near Infrared Spectroscopy. (2017) (15)
Patient-Reported Outcomes in Atrial Fibrillation Research: Results of a Clinicaltrials.gov Analysis. (2019) (15)
Evaluation of resynchronization therapy for heart failure in patients with a QRS duration greater than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristics. (2011) (15)
Acceptability of a Cognitive Behavior Therapy Intervention to Implantable Cardioverter Defibrillator Recipients (2010) (15)
Isoproterenol antagonizes drug-induced prolongation of action potential duration in humans. (1993) (15)
The Risk Stratification and Stroke Prevention Therapy Care Gap in Canadian Atrial Fibrillation Patients. (2016) (15)
Prescribing of oral anticoagulants in the emergency department and subsequent long-term use by older adults with atrial fibrillation (2019) (15)
Defibrillation Strategies for Refractory Ventricular Fibrillation. (2022) (15)
Effects of Rotigaptide, a Gap Junction Modifier, on Defibrillation Energy and Resuscitation From Cardiac Arrest in Rabbits (2007) (15)
Identifying Predictors of Cumulative Healthcare Costs in Incident Atrial Fibrillation: A Population‐Based Study (2015) (15)
The effects of an automatic, low pressure and constant flow ventilation device versus manual ventilation during cardiovascular resuscitation in a porcine model of cardiac arrest. (2013) (14)
Intravenous antiarrhythmic agents. (2001) (14)
The impact of hospital experience with out-of-hospital cardiac arrest patients on post cardiac arrest care. (2017) (14)
The class III effect of azimilide is not associated with reverse use-dependence in open-chest dogs. (1999) (14)
Characterization of the ultrashort‐TE (UTE) MR collagen signal (2015) (14)
Assessment of Resynchronization Therapy on Functional Status and Quality of Life in Patients Requiring an Implantable Defibrillator (2009) (14)
Health care utilization prior to out-of-hospital cardiac arrest: A population-based study. (2019) (14)
Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo) (2017) (14)
Hyperaldosteronism and sudden cardiac death. (1996) (14)
Common wearable devices demonstrate variable accuracy in measuring heart rate during supraventricular tachycardia. (2020) (14)
Mechanisms of action of class III agents and their clinical relevance. (2000) (14)
Wavelet-based markers of ventricular fibrillation in optimizing human cardiac resuscitation (2010) (13)
Role of Amiodarone in the Era of the Implantable Cardioverter Defibrillator (2003) (13)
Combination ICD and drug treatments-best options. (2000) (13)
Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias. (1986) (13)
Screening for Cardiovascular Disease Risk With Electrocardiography. (2018) (13)
Applying the new STEMI guidelines: 1. Reperfusion in acute ST-segment elevation myocardial infarction (2004) (13)
Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis (2020) (13)
Cardiac effects of CPAP treatment in patients with obstructive sleep apnea and atrial fibrillation (2018) (13)
Isoproterenol Increases Defibrillation Energy Requirements in Dogs (1992) (13)
The relationship between satellite-inferred frontogenesis and squall line formation (1988) (12)
Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia. (1993) (12)
Improving stroke prevention therapy for patients with atrial fibrillation in primary care: protocol for a pragmatic, cluster-randomized trial (2016) (12)
Rationale and design of the Home Automatic External Defibrillator Trial (HAT). (2008) (12)
Counterpoint: implantable cardioverter-defibrillator shocks for ventricular tachyarrhythmias do not increase mortality. (2012) (12)
Barium Decreases Defibrillation Energy Requirements (1994) (12)
Mortality Risk Increases With Clustered Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators. (2020) (12)
Oral Anticoagulation for Stroke Prevention in Canadian Practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry(.). (2016) (12)
Meta-Analysis of Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin According to Time in Therapeutic Range in Atrial Fibrillation. (2020) (12)
Canadian Cardiovascular Society commentary on implantable cardioverter defibrillators in Canada: waiting times and access to care issues. (2005) (12)
Sotalol in patients with implanted automatic defibrillators: effects on defibrillation and comparison with amiodarone. (1994) (12)
Atrial Fibrillation Clinics in Canada: A Nationwide Project Report. (2018) (12)
The Future of Atrial Fibrillation Therapy (2006) (12)
"Presumed cardiac" arrest in children and young adults: A misnomer? (2017) (12)
Rate control in atrial fibrillation: looking beyond the average heart rate (2006) (12)
Canadian Cardiovascular Society Cardiovascular Screening of Competitive Athletes: The Utility of the Screening Electrocardiogram to Predict Sudden Cardiac Death. (2019) (12)
The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C‐CUSP ED) (2019) (11)
Real-time electrogram analysis for monitoring coronary blood flow during human ventricular fibrillation: implications for CPR. (2011) (11)
Systematic evaluation of the determinants of defibrillation efficacy. (2005) (11)
Primary Prevention Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy - Are There Predictors of Appropriate Therapy? (2020) (11)
Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation (2014) (11)
Catheter ablation for atrial flutter: a survey by the European Heart Rhythm Association and Canadian Heart Rhythm Society. (2016) (11)
The prevention and management of sudden cardiac arrest in athletes (2019) (11)
Results of a curtailed randomized controlled trial, evaluating the efficacy and safety of azimilide in patients with implantable cardioverter‐defibrillators: The SHIELD‐2 trial (2017) (10)
APIXABAN REDUCES HOSPITALIZATION IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS OF THE EFFECT OF APIXABAN THERAPY ON RESOURCE USE IN THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION TRIAL (2013) (10)
The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation (2021) (10)
Effect of physiological mechanical perturbations on intact human myocardial repolarization. (2000) (10)
Economic Analysis of a Randomized Trial of Biventricular Pacing in Canada (2007) (10)
The Effect of Isoproterenol on the Class III Effect of Azimilide in Humans (2002) (10)
The impact of implantable cardiac defibrillators for primary prophylaxis in the community: baseline risk and clinically meaningful benefits. (2006) (10)
The Burden of Atrial Fibrillation: Should We Abandon Antiarrhythmic Drug Therapy? (2004) (10)
Advances in the acute pharmacologic management of cardiac arrhythmias (2003) (10)
The effect of sinus node depression on heart rate variability in humans using zatebradine, a selective bradycardic agent. (1998) (10)
Amiodarone and Defibrillation Thresholds: (2000) (10)
β-Blockers and atrial fibrillation: hypertension and other medical conditions influencing their use. (2014) (9)
Pharmacological and nonpharmacological methods for rate control. (2005) (9)
Health-related quality of life questionnaires: an important method to evaluate patient outcomes in atrial fibrillation ablation (2013) (9)
Association Between Hospital Teaching Status and Outcomes After Out-of-Hospital Cardiac Arrest. (2019) (9)
Left Ventricular Performance During Acute Rate Control in Atrial Fibrillation: The Importance of Heart Rate and Agent Used (2003) (9)
Universal access -- but when? Treating the right patient at the right time: access to electrophysiology services in Canada. (2006) (9)
Excessive exercise in endurance athletes: Is atrial fibrillation a possible consequence? (2018) (9)
Amiodarone Interaction With (cid:98) -Blockers Analysis of the Merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) Databases amiodarone in patients after myocardial infarction with sim-Received (1999) (9)
Cellular mechanism underlying the efficacy of the sotalol-quinidine combination. (1993) (9)
Evaluation of zopiclone physical dependence liability in normal volunteers. (1982) (9)
Healthcare costs and resource utilization associated with treatment of out-of-hospital cardiac arrest. (2020) (9)
Optimizing cardiac resuscitation outcomes using wavelet analysis (2009) (9)
Near-Infrared Spectroscopy to Assess Cerebral Autoregulation and Optimal Mean Arterial Pressure in Patients With Hypoxic-Ischemic Brain Injury: A Prospective Multicenter Feasibility Study (2020) (8)
Torsades de pointes ventricular tachycardia following right pneumonectomy: insights into the relation between right cardiac sympathetic nerve damage, QT intervals, and arrhythmias. (1994) (8)
Cloud Cover Estimation Using Bispectral Satellite Measurements (1986) (8)
Characteristics and evidence-based management of stable coronary artery disease patients in Canada compared with the rest of the world: insights from the CLARIFY registry. (2014) (8)
Antiarrhythmic drugs and ventricular defibrillation energy requirements. (1999) (8)
Antiarrhythmic Drug Therapy of Atrial Fibrillation: Focus on New Agents (2003) (8)
Clinically Important Drug–Drug Interactions Between Antiarrhythmic Drugs and Anticoagulants (2019) (8)
Approach to antiarrhythmic therapy in patients with ICDs and frequent activations (2005) (8)
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry (2018) (8)
Permanent Explantation of Implantable Cardioverter Defibrillators (2000) (7)
The resuscitation outcomes consortium (ROC) primed impedance threshold device (ITD) cardiac arrest trial: A prospective, randomised, double-blind, controlled clinical trial (2010) (7)
Association of prior β-blocker use and the outcomes of patients with out-of-hospital cardiac arrest. (2015) (7)
A population-based method for the estimation of defibrillation energy requirements in humans. Assessment of time-dependent effects with a transvenous defibrillation system. (1997) (7)
Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT). (2010) (7)
A clinical decision instrument to predict 30‐day death and cardiovascular hospitalizations after an emergency department visit for atrial fibrillation: The Atrial Fibrillation in the Emergency Room, Part 2 (AFTER2) study (2018) (7)
The impact of left ventricular dysfunction on outcomes with the implantable defibrillator. (1994) (7)
Analysis of electrocardiogram pre-shock waveforms during ventricular fibrillation (2015) (7)
Use of apixaban and warfarin in patients undergoing invasive procedures : insights from ARISTOTLE (2013) (7)
Electrogram-based optimal atrioventricular and interventricular delays of cardiac resynchronization change individually during exercise. (2011) (7)
Counterpoint: implantable cardioverter-defibrillator shocks for ventricular tachyarrhythmias increase mortality. (2012) (7)
Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation: the clinical dilemma of triple therapy (2014) (7)
Paroxysmal atrial fibrillation and health-related quality of life: the importance of keeping score. (2010) (7)
Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients (1998) (7)
Cyclosporine nephrotoxicity and cyclosporine--digoxin interaction prior to heart transplantation. (1987) (7)
Limitations in the current screening practice of assessing left ventricular ejection fraction for a primary prophylactic implantable defibrillator in southern Ontario. (2010) (7)
Chapter 5 – Principles of Clinical Pharmacology (2005) (7)
A Comparison of Two Nights of Ambulatory Sleep Testing in Arrhythmia Patients (2018) (7)
Left Ventricular Fibrosis in Middle-Age Athletes and Physically Active Adults (2020) (7)
Benefits and Risks of Anticoagulation in Dialysis Patients With Nonvalvular Atrial Fibrillation: Navigating Through Darkness. (2020) (6)
UNDERUSE OF FULL DOSE FACTOR XA INHIBITION IN ATRIAL FIBRILLATION: INSIGHT FROM THE SPRINT-AF REGISTRY (2015) (6)
Field Implementation of Remote Ischemic Conditioning in ST-Segment-Elevation Myocardial Infarction: The FIRST Study. (2019) (6)
IKs Block by HMR 1556 Lowers Ventricular Defibrillation Threshold and Reverses the Repolarization Shortening by Isoproterenol Without Rate‐Dependence in Rabbits (2007) (6)
Health-Related Quality of Life in Patients With Atrial Fibrillation Treated With Catheter Ablation or Antiarrhythmic Drug Therapy: A Systematic Review and Meta-analysis (2020) (6)
Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study. (2021) (6)
ECG Features Associated With Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation: A Combined AFFIRM and AF‐CHF Analysis (2016) (6)
Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation. (2015) (6)
Novel risk factors for coronary artery disease (2001) (6)
Effective and efficient use of implantable defibrillators: Sometimes it's over when it's over (2009) (6)
Management of direct oral anticoagulant associated bleeding: Results of a multinational survey. (2018) (6)
Etiology and initial investigation. (2005) (6)
Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator? (2014) (6)
Policies to Prevent Sudden Cardiac Death in Young Athletes: Challenging, But More Testing Is Not the Answer (2020) (6)
Does location matter? A proposed methodology to evaluate neighbourhood effects on cardiac arrest survival and bystander CPR. (2015) (6)
Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients (2015) (6)
Comparison of health-related quality of life in patients with atrial fibrillation treated with catheter ablation or antiarrhythmic drug therapy: a systematic review and meta-analysis protocol (2017) (6)
Restoring sinus rhythm in atrial fibrillation: a Pyrrhic victory? (2003) (6)
Downward delegation of implantable cardioverter defibrillator decision-making in a restricted-resource environment: the pitfalls of bedside rationing. (2005) (6)
Rhythm and rate control of atrial fibrillation in the emergency department - A large community-based observational study. (2018) (5)
Use of Apixaban and Warfarin in Patients Undergoing Invasive Procedures: Insights From Aristotle (2013) (5)
Effect of alcohol on propylthiouracil disposition (1983) (5)
Implantable Cardioverter Defibrillator Implantation Rates After Out of Hospital Cardiac Arrest: Are the Rates Guideline-Concordant? (2017) (5)
QUALITY OF LIFE COMPARISON BETWEEN THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR AND AMIODARONE (1999) (5)
Sunday, 26 August 2012 (2012) (5)
Greater mortality risk among patients with delayed follow-up after implantable cardioverter defibrillator procedures. (2013) (5)
Complications of variant angina: a case report. (2012) (5)
Primary angioplasty in acute myocardial infarction (2003) (5)
Dual Device Therapy in the Setting of Changing ICD Technology: Device‐Device Interaction Revisited (1997) (5)
Developing a Pan-Canadian Registry of Sudden Cardiac Arrest: Challenges and Opportunities (2019) (5)
Responding to Cardiac Arrest in the Community in the Digital Age: (2021) (5)
Shared Decision Making and the Cardiovascular Care of Athletes: Is It Time to Get Back in the Game? (2019) (5)
Bronchoenteric fistula from an infected internal cardioverter defibrillator. (1992) (5)
Can Antiarrhythmic Agents be Selected Based on Mechanism of Action? (2000) (5)
Exercise in Hypertrophic Cardiomyopathy: Restrict or Rethink?? (2021) (5)
Stem Cells for Myocardial Revascularization and Regeneration (2004) (5)
DOuble SEquential External Defibrillation for Refractory Ventricular Fibrillation (DOSE VF): study protocol for a randomized controlled trial (2020) (5)
The management of acute ventricular tachycardia or fibrillation. (2000) (5)
Clinical characteristics and outcomes of acute coronary syndrome patients with left anterior hemiblock (2014) (5)
EVALUATION OF HEART RATE TRACKERS IN PATIENTS WITH ATRIAL FIBRILLATION (2018) (5)
Antiarrhythmic drugs in atrial fibrillation: do they have a future? (2013) (5)
Importance of ST-segment depression as a determinant of ventricular premature complex frequency after thrombolysis for acute myocardial infarction. Tissue Plasminogen Activator: Toronto (TPAT) Study Group. (1994) (5)
Interactions Between Implantable Devices and Antiarrhythmic Drugs (2000) (4)
P3580Which factors influence the choice of a non-vitamin K oral anticoagulant over warfarin for stroke prevention among atrial fibrillation patients? Insights from the prospective SPRINT-AF registry (2017) (4)
Cardiac Remodeling in Middle-Aged Endurance Athletes and Recreationally Active Individuals: Challenges in Defining the "Athlete's Heart". (2019) (4)
Partnering with survivors & families to determine research priorities for adult out-of-hospital cardiac arrest: A James Lind Alliance Priority Setting Partnership (2021) (4)
Validation of a Noninvasive Measure of Local Myocardial Repolarization in a Conscious Human Model: (1999) (4)
SURVIVAL BENEFIT OF THE PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AMONG OLDER PATIENTS: DOES AGE MATTER? A PATIENT-LEVEL META-ANALYSIS OF 5 CLINICAL TRIALS (2014) (4)
Using Transthoracic Two‐Dimensional Echocardiography to Guide the Placement of Coronary Sinus Catheters: A Randomized Study (2006) (4)
How Are n-3 LCPUFAs Antiarrhythmic? A Reassessment of n-3 LCPUFAs in Cardiac Disease (2012) (4)
Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation. (2019) (4)
Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: what are the risks of waiting? (2009) (4)
Psychiatric Assessment of Patients with Life-Threatening Cardiac Arrhythmias (1993) (4)
Mandating Training Is Not Enough: The State of Cardiopulmonary Resuscitation and Automated External Defibrillator Training in Ontario Schools (2021) (4)
Fish oil supplementation and arrhythmias. (2005) (4)
Iron-overload Cardiomyopathy Associated with Iron-overload Conditions: Incidence, Pathophysiology, and Treatment (2007) (4)
Effects of magnesium on ischemic and reperfusion arrhythmias in the rat heart and electrophysiologic effects of hypermagnesemia in the anesthetized dog (1988) (4)
Omega-3 polyunsaturated fatty acids: food or medicine? (2011) (4)
A Systematic Review of the Risk of Motor Vehicle Collision in Patients With Syncope. (2020) (4)
PREDICTORS OF DEATH AND STROKE IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION: Results FROM THE CANADIAN REGISTRY OF ATRIAL FIBRILLATION (2014) (4)
900 Efficacy and safety of apixaban compared to warfarin for prevention of stroke and systemic embolism in 18,201 patients with atrial fibrillation: Primary results of the ARISTOTLE Trial (2011) (4)
The Role of Quality of Life Indices in Patient-Centred Management of Arrhythmia. (2020) (4)
Association Between Physicians’ Appropriate Use of Echocardiography and Subsequent Healthcare Use and Outcomes in Patients With Heart Failure (2019) (4)
Society Guidelines 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation (2014) (3)
Predicting refibrillation from pre-shock waveforms in optimizing cardiac resuscitation (2011) (3)
[Etiologies of electric storm]. (1997) (3)
Abstract 53: Evidence for Circadian Variability in the Frequency of Out-of-Hospital Cardiac Arrest (2007) (3)
Relationship between right and left ventricular function in candidates for implantable cardioverter defibrillator with low left ventricular ejection fraction (2016) (3)
Impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for implantable cardioverter defibrillators (2011) (3)
Can diagnostic and procedural skills required to practice cardiology as a specialist be mastered in 3 years? (2015) (3)
Combination IK1 and IKr channel blockade: no additive lowering of the defibrillation threshold. (2002) (3)
Lack of difference in T wave variability between patients at risk of sudden cardiac death and healthy subjects. (2014) (3)
Angiotensin receptor blockade in the treatment of heart failure: New data from the Valsartan Heart Failure Trial (Val-HeFT) (2002) (3)
APPROPRIATENESS OF NON-VITAMIN K ORAL ANTICOAGULANT DOSING AMONG CANADIAN ATRIAL FIBRILLATION PATIENTS (2017) (3)
Cardiac MRI and radionuclide ventriculography for measurement of left ventricular ejection fraction in ICD candidates. (2018) (3)
Development of Acute Myocardial Infarction Mortality and Readmission Models for Public Reporting on Hospital Performance in Canada (2021) (3)
Dronedarone and Captisol-enabled Amiodarone in an Experimental Cardiac Arrest (2013) (3)
Refined risk stratification by heart rate turbulence in patients with reduced left ventricular function early after myocardial infarction: Results of the DINAMIT Holter substudy (2005) (3)
Prevention and Treatment of Life‐Threatening Ventricular Arrhythmia and Sudden Death (2007) (3)
Abstract 809: EQ-5D Utility Index in Atrial Fibrillation: Insights From a Large Multinational Registry of Atrial Fibrillation (Record-AF) (2009) (3)
Angiogenesis: An emerging technology for the treatment of coronary artery disease (2001) (3)
Retrieving AEDs to save a life: more complicated than it seems. (2020) (3)
Evaluation of the Risk of Stroke Without Anticoagulation Therapy in Men and Women With Atrial Fibrillation Aged 66 to 74 Years Without Other CHA2DS2-VASc Factors. (2021) (3)
Simultaneous measurement of cerebral and muscle tissue parameters during cardiac arrest and cardiopulmonary resuscitation (2015) (3)
Applying the atrial fibrillation guidelines update to manage your patients with atrial fibrillation. (2014) (3)
Bystander interventions and survival after exercise-related sudden cardiac arrest: a systematic review (2021) (3)
A Gas-Powered, Patient-Responsive Automatic Resuscitator for Use in Acute Respiratory Failure: A Bench and Experimental Study (2020) (3)
Right Ventricular Function at Cardiac MRI Predicts Cardiovascular Events in Patients with an Implantable Cardioverter-Defibrillator. (2021) (2)
Impact of Choice of Prophylaxis on the Microbiology of Cardiac Implantable Electronic Device Infections: Insights From the Prevention of Arrhythmia Device Infection Trial (PADIT) (2021) (2)
Establishing a multicenter, preclinical consortium in resuscitation: A pilot experimental trial evaluating epinephrine in cardiac arrest. (2022) (2)
Device therapy: Who may and who may not benefit from an ICD? (2011) (2)
Ethanol-induced inhibition of hepatic uptake of propranolol in perfused rat liver and in man (2004) (2)
Chronic drug therapy to prevent recurrence of atrial fibrillation. (1996) (2)
Sustainable Practice 'In Action': Adult Learning in a Masters Program (2006) (2)
Limitations of triple-angle radiometric geosurface measurements from high altitude to mitigate low-absorption atmospheric effects (1995) (2)
IMPLANTABLE DEFIBRILLATORS AND/OR AMIODARONE: ALTERNATIVES OR COMPLEMENTARY THERAPIES (1998) (2)
Society Guidelines The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure (2013) (2)
Prolonged P wave duration is associated with right atrial dimensions, but not atrial arrhythmias, in middle-aged endurance athletes. (2019) (2)
Clinical Significance of Left Anterior Hemiblock in Acute Coronary Syndromes (2013) (2)
Low-Value Transthoracic Echocardiography, Healthcare Utilization, and Clinical Outcomes in Patients With Coronary Artery Disease. (2019) (2)
Impact of electrical cardioversion on quality of life for patients with symptomatic persistent atrial fibrillation: Is there a treatment expectation effect? (2020) (2)
THE CHA2DS2-VASC SCORE IDENTIFIES AF PATIENTS WITH A CHADS2 SCORE OF 0 OR 1 TREATED WITH ANTIPLATELET THERAPY WHO ARE UNLIKELY TO BENEFIT FROM ORAL ANTICOAGULANT THERAPY (2012) (2)
Cardiac myocyte transplantation does not increase global epicardial repolarization heterogeneity in a rat infarct model. (2007) (2)
HIGH RATES OF CONCOMITANT ANTIPLATELET USE IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ORAL ANTICOAGULATION: INSIGHTS FROM THE STROKE PREVENTION AND RHYTHM INTERVENTIONS IN ATRIAL FIBRILLATION (SPRINT-AF) REGISTRY (2014) (2)
ACE inhibitors after myocardial infarction. (1993) (2)
High Risk Neighbourhoods: The Effect of Neighbourhood Level Factors on Cardiac Arrest Incidence. (2020) (2)
Blind source separation in characterizing ECG pre-shock waveforms during ventricular fibrillation (2013) (2)
Dantrolene Improves Survival Following Ventricular Fibrillation by Mitigating Impaired Calcium Handling in Animal Models (2013) (2)
Abstract 16741: The Cost-Effectiveness of Apixaban versus Warfarin in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Study Group (2014) (2)
Assessing arrhythmia risk in a 15-year-old boy whose father died suddenly (2016) (2)
Bayesian analysis of amiodarone or lidocaine versus placebo for out-of-hospital cardiac arrest (2022) (2)
Evaluation and care of a patient with new-onset atrial fibrillation (2014) (2)
Utility of anti-arrhythmic medications in 'lone atrial fibrillation'. (2014) (2)
Initial clinical experience with second generation implantable defibrillator (1990) (2)
Folie à deux: an old diagnosis with a new technology. (2003) (2)
Sustained Ventricular Tachycardia with Heart Disease (2005) (2)
Interactions Between Implantable Devices and Pharmacological Agents (1998) (2)
Retracted. Catheter ablation for atrial flutter: a survey by the European Heart Rhythm Association and Canadian Heart Rhythm Society. (2016) (2)
HOW ACCURATE IS THE ECG IN SCREENING FOR HYPERTROPHIC CARDIOMYOPATHY? (2018) (2)
Cardiac Arrest during Competitive Sports. (2018) (2)
Papillary muscle rupture post-myocardial infarction (2003) (2)
Understanding Etiologies of Cardiac Arrest: Seeking Definitional Clarity. (2022) (2)
Response to letter regarding article, "Survival after implantable cardioverter-defibrillator implantation in the elderly". (2014) (2)
Predicting Sudden Cardiac Death After Myocardial Infarction: A Great Unsolved Challenge. (2021) (2)
Does better rate control improve quality of life? Be still my beating heart. (2011) (2)
Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: a novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillator. (2005) (2)
Quantitative assessment of brain tissue oxygenation in porcine models of cardiac arrest and cardiopulmonary resuscitation using hyperspectral near-infrared spectroscopy (2014) (2)
Effects of an alert system on implantable cardioverter defibrillator-related anxiety: rationale, design, and endpoints of the PANORAMIC multicentre trial. (2010) (2)
Single-chamber, rate-responsive pacemaker-mediated tachycardia. (2010) (2)
Irish Cardiac Society (1994) (1)
Mechanisms of ethanol drug interactions (1982) (1)
Detecting Patients With Nonvalvular Atrial Fibrillation and Atrial Flutter in the Canadian Primary Care Sentinel Surveillance Network: First Steps (2020) (1)
PREVALENCE OF LATE GADOLINIUM ENHANCEMENT IN MIDDLE-AGED, SUB-ELITE ATHLETES (2016) (1)
The role of bystander-initiated basic life support in exercise-related sudden cardiac arrest: a systematic review (2021) (1)
Association between sex and survival after non-traumatic out of hospital cardiac arrest: A systematic review and meta-analysis. (2022) (1)
Regarding manuscript: "resuscitation outcomes consortium-amiodarone, lidocaine, or placebo study: rationale and methodology behind out-of-hospital cardiac arrest antiarrhythmic drug trial". (2014) (1)
Cardiac remodeling in middle-aged endurance athletes: relation between signal-averaged electrocardiogram and LV mass. (2020) (1)
Abstract P18: Automated High Frequency Ventilation During Experimental CPR: A New Approach to Resuscitation (2008) (1)
Atrial structure and function in middle‐aged, physically‐active males and females: A cardiac magnetic resonance study (2021) (1)
Factitious ventricular tachyarrhythmia outbreak. (2011) (1)
540 Variability in Potential Causal Factors Between “Cardiotoxic” Neighbourhoods With High Incidence of Out-of-Hospital Cardiac Arrest (2012) (1)
TRANSITIONING EMERGENCY ATRIAL FIBRILLATION MANAGEMENT (TEAM): INTERIM ANALYSIS OF IMPACT ON CLINICAL OUTCOMES (2020) (1)
Abstract P191: Rapid Surface Cooling in Unconscious Post Resuscitation Patients Following Cardiac Arrest: Safety, Efficacy, and Outcomes (2008) (1)
THE EFFECT OF GENDER ON SURVIVAL FROM SUDDEN CARDIAC DEATH IN THE YOUNG (2016) (1)
T1-MAPPING DERIVED CARDIAC EXTRACELLULAR VOLUME IN MIDDLE-AGED ENDURANCE ATHLETES AND RECREATIONALLY-ACTIVE ADULTS (2017) (1)
Employing knowledge translation interventions to increase the use of therapeutic hypothermia post arrest: the SPARC Network Trial (2011) (1)
Cardioversion for Atrial Fibrillation Improves Quality of Life: It's Obvious (or Isn't It?). (2017) (1)
Trials and tribulations: Antiarrhythmic drugs for the acute conversion of atrial fibrillation. (2016) (1)
A mesoscale gravity wave event observed during CCOPE. II - Interactions between mesoscale convective systems and the antecedent waves. [Cooperative Convection Precipitation Experiment] (1988) (1)
Inadvertent Defibrillator Sense/Pace Lead Placement in the Middle Cardiac Vein: A Possible Complication with New Implications (1994) (1)
Predicting Sudden Death in Dilated Cardiomyopathy: The Potential Power of Magnetic Resonance Imaging as a Critical Tool. (2019) (1)
COMMON WEARABLE FITNESS DEVICES DEMONSTRATE VARIABLE ACCURACY IN MEASURING HEART RATE DURING SUPRAVENTRICULAR TACHYCARDIA (2019) (1)
GREATER TORONTO AREA HEART MAP CHALLENGE: THE FIRST CROWD-SOURCED AUTOMATED EXTERNAL DEFIBRILLATOR REGISTRY IN CANADA (2020) (1)
Symptoms and Quality of Life After Atrial Fibrillation Ablation: Two Different Concepts. (2017) (1)
Are Calcium Channel Blockers Safe Post-Myocardial Infarction? The CAMI Experience (1997) (1)
Canada-wide mixed methods analysis evaluating the reasons for inappropriate emergency department presentation in patients with a history of atrial fibrillation: the multicentre AF-ED trial (2020) (1)
Single centre experience with a combination antitachycardia pacemaker and defibrillator (1991) (1)
Characterization of the ultra-short echo time magnetic resonance (UTE MR) collagen signal associated with myocardial fibrosis (2015) (1)
Abstract 4634: Profile of Patients According to Chosen Therapeutic Strategy in the RecordAF Global Registry on Atrial Fibrillation Management (2008) (1)
Abstract 2659: Effect of an Automated Ventilator and the Impedance Threshold Device on Coronary Perfusion Pressure and Cerebral Blood Flow During Cardiopulmonary Resuscitation in Pigs (2006) (1)
Emergency arrhythmia management: an assessment of learning needs. (1997) (1)
Clinical performance of the wavelet TM automatic electrogram template collection algorithm (2003) (1)
Abstract 174: Cardiotoxic Neighborhoods: Marked Variations in Domiciles of Victims of Cardiac Arrest Within a Large Urban Area (2011) (1)
Utility of long temporary epicardial wire electrodes for post-operative pacing and atrial defibrillation (1997) (1)
USE OF A CARDIAC ELECTROCARDIOGRAPHY AND TRANSTHORACIC ECHOCARDIOGRAPHY DATABASE TO REDEFINE ECG CRITERIA FOR LEFT VENTRICULAR HYPERTROPHY (THE CREATED-LVH STUDY) (2011) (1)
The association of maximum Troponin values post out-of-hospital cardiac arrest with electrocardiographic findings, cardiac reperfusion procedures and survival to discharge: A sub-study of ROC PRIMED. (2017) (1)
Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization Therapy. (2018) (1)
Near Infrared Spectroscopy (NIRS) Reveals the Effect Epinephrine on Cerebral Oxygen Delivery and Metabolism During Cardiac Arrest (2018) (1)
In Response: Adenosine for Maternal Supraventricular Tachycardia and Preterm Delivery (2011) (1)
Abstract 2686: Survival Unchanged Five Months After Implementing The 2005 AHA CPR And ECC Guidelines For Out-of-hospital Cardiac Arrest (2008) (1)
Behavior of a respiratory rate-responsive pacemaker during and after cardiac surgery. (1994) (1)
P3753Does empagliflozin modulate the autonomic system among patients with type 2 diabetes and coronary artery disease? Insights from the Holter sub-study of the EMPA-Heart CardioLink-6 Randomised Trial (2019) (1)
[Long term drug therapy for the prevention of recurrence in atrial fibrillation]. (1996) (1)
A Novel Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Biomarker—Anti-DSG2—Is Absent in Athletes With Right Ventricular Enlargement (2021) (1)
Implanted cardioverter defibrillators for the prevention of sudden death. (2005) (1)
Terikalant and Barium Decrease the Area of Vulnerability to Ventricular Fibrillation Induction by T-Wave Shocks (2002) (1)
Atrial Fibrillation Innovation Program: Transitioning Emergency Atrial Fibrillation Management (Team) - Lessons From A Feasibility Trial (2013) (1)
Serial Measures of Sinoatrial and Atrioventricular Nodal Function in Ambulatory Patients (1997) (1)
Abstract 2934: Prolonged QRS Duration is Associated with a Marked Increase in Mortality in the AF-CHF Study (2008) (1)
Symptoms in Atrial Fibrillation: Patient and Physician Perspectives. (2021) (1)
Pattern of Atrial Fibrillation and Cognitive Function in Young Patients With Atrial Fibrillation and Low CHADS2 Score: Insights From the BRAIN-AF Trial. (2022) (1)
COVID-19, Inflammatory Heart Disease, and Vaccination in the Athlete and Highly Active Person: An Update and Further Considerations (2022) (1)
The Potential Impact of Intrathoracic Impedance on Defibrillation Threshold Testing in S-ICDs. (2019) (1)
Spurious detection of a high serum imipramine level due to coating of Vacutainer stopper. (1982) (1)
Survival unchanged 5 months after implementing the 2005 American Heart Association cardiopulmonary resuscitation and emergency cardiac care guidelines for out-of-hospital cardiac arrest (2009) (1)
Assessment of Sleep and Mood Symptoms in Patients with Undetected Obstructive Sleep Apnea and Atrial Fibrillation (2018) (1)
Evaluating the 12-Lead Electrocardiogram for Diagnosing ARVC in Young Populations: Implications for Preparticipation Screening of Athletes (2020) (1)
Improving Resuscitation Rates After Out-of-Hospital Cardiac Arrest: It’s Complicated (2019) (1)
Whom do you believe? The patient or the ECG? (2015) (1)
Anti-Arrhythmic Drugs (2021) (1)
Psychiatric treatment strategies for patients at risk of dying suddenly. (1991) (1)
Validation Of The Apixaban Cost-Effectiveness Model In Patients With Non-Valvular Atrial Fibrillation (2014) (1)
Drug-eluting stents for the treatment of coronary artery disease Part 4: New results from clinical trials and future directions. (2003) (1)
Omega-3 Polyunsaturated Fatty Acids (Fish Oils) and Heart Disease - Clinical Benefit or Just a Fad? (2008) (1)
Effect of Time to Treatment With Antiarrhythmic Drugs on Return of Spontaneous Circulation in Shock‐Refractory Out‐of‐Hospital Cardiac Arrest (2022) (1)
Avoiding Clinical Errors With Bedside Echocardiography: A Randomized Clinical Study. (2018) (1)
0601 DETECTION OF OBSTRUCTIVE SLEEP APNEA AND ASSESSMENT OF SLEEP AND MOOD SYMPTOMS IN ARRHYTHMIA CLINIC OUTPATIENTS (2017) (1)
A little cheese, a big cheese and the novel anticoagulants (2014) (1)
EVALUATION OF ATRIAL FIBRILLATION STROKE PREVENTION THERAPIES IN THE ERA OF NOACS AND EVOLVING ANTICOAGULATION GUIDELINES IN CANADA (2015) (1)
Guideline Based Stroke Prevention in Atrial Fibrillation Patients Presenting to the Emergency Department: Are Women Still Undertreated? (2013) (0)
Development of a ‘Simplified Clinical Assessment Checklist’ in Atrial Fibrillation Care: Implications to Nursing Practice” (2016) (0)
Visits and Hospitalizations in Patients With an Implantable Cardioverter-Defibrillator in a Placebo-Controlled Clinical Trial (2016) (0)
Abstract 41: Liquid Convection Surface Cooling Leads to High Rate of Recovery of Post-VT/VF Patients (2011) (0)
Abstract 1655: A Prospective Study of the Effect of ICD’s on Patient Quality of Life (2007) (0)
Interpreting observational data on adrenaline in cardiac arrest is complicated. (2019) (0)
Abstract 9791: Sex Disparities in Implantable Cardioverter Defibrillator (ICD) Outcomes: Findings From the Ontario ICD Database (2011) (0)
The implantable defibrillator and antiarrhythmic drugs—competitive and complementary treatment for severe ventricular arrhythmia (1993) (0)
STRESS ELECTROCARDIOGRAPHIC INTERPRETATION SKILLS OF CARDIOLOGY TRAINEES: ARE THEY COMPETENT? (2015) (0)
Abstract 342: Developing an In Vivo Model of Ventricular Refibrillation (2012) (0)
HOW SENSITIVE IS ADMINISTRATIVE CODING FOR ATRIAL FIBRILLATION AND ATRIAL FLUTTER (2015) (0)
Abstract 15378: The Association of First Responder Response Time and Outcomes in Out-of-Hospital Cardiac Arrest (2017) (0)
Reply to: Kumar et al. "Double Sequential External Defibrillation". (2020) (0)
THE RELATIONSHIP BETWEEN FEMALE SEX AND STROKE RATE IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION (2022) (0)
ASSOCIATION OF SODIUM/GLUCOSE COTRANSPORTER-2 INHIBITORS WITH OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ATRIAL FIBRILLATION (2022) (0)
758 High Use of Guideline-Recommended Therapies in Canadian Outpatients with Stable Coronary Artery Disease: Insights From the Prospective Observational Longitudinal Registry of Patients With Stable Coronary Artery Disease (CLARIFY) Registry (2012) (0)
Abstract 13047: Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators (ICDs) (2014) (0)
Monitoring cerebral oxygenation and metabolism during cardiac arrest and CPR using hyperspectral near infrared spectroscopy (hNIRS) (2016) (0)
638 Outcomes of primary prevention implantable cardioverter defibrillator (ICD) recipients with vs without clinical trial entry criteria: Observations from a comprehensive provincial ICD registry (2011) (0)
The Physical Activity Levels and Sitting Time of Adults Living With Atrial Fibrillation: The CHAMPLAIN-AF Study (2022) (0)
Corrigendum to "Long-term clinical outcomes and predictors for survivors of out-of-hospital cardiac arrest" [Resuscitation 112 (2016) 59-64]. (2017) (0)
FACTORS ASSOCIATED WITH NEW ORAL ANTICOAGULANT VERSUS VITAMIN K ANTAGONIST USE IN A CONTEMPORARY, NATIONAL, REAL-WORLD OBSERVATIONAL REGISTRY: INSIGHTS FROM THE STROKE PREVENTION AND RHYTHM INTERVENTIONS IN ATRIAL FIBRILLATION (SPRINT-AF) REGISTRY (2014) (0)
Abstract 96: Real-Time Electrogram Characteristics During Human Ventricular Fibrillation for Quantification of the Antegrade Coronary Flow to Optimize Resuscitation Outcomes (2010) (0)
340 How Do Canadian Patients With Stable Coronary Artery Disease Compare to the Rest of the World? A Description of Secondary Prevention Targets in the Prospective Observational Longitudinal Registry of Patients With Stable Coronary Artery Disease (Clarify) Registry (2012) (0)
Impact of Cardiovascular Magnetic Resonance Assessment of Ejection Fraction on Eligibility for Cardioverter Defibrillator Implantation (2012) (0)
Troponin: A window for assessing the high cardiovascular mortality in chronic renal failure (2003) (0)
HOW USEFUL IS A PRE-PARTICIPATION SCREENING PROGRAM TO PREVENT CARDIAC ARREST DURING SPORT? INSIGHTS FROM A REGISTRY OF ALL SPORTS-RELATED CARDIAC ARRESTS IN A LARGE URBAN POPULATION (2015) (0)
A 26-year-old competitive soccer player with syncope (2015) (0)
P4591Outcomes of stable coronary artery disease worldwide. Insights from the CLARIFY registry (2018) (0)
CONCOMITANT USE OF ANTIPLATELET AND ORAL ANTICOAGULATION AMONG PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY (2017) (0)
EXAGGERATED BLOOD PRESSURE RESPONSE TO EXERCISE IN MIDDLE AGE ENDURANCE-TRAINED ATHLETES (2015) (0)
062 ECG Predictors of Adverse Outcomes in Patients With Atrial Fibrillation: A Combined Affirm and AF-CHF Sub-Study (2012) (0)
Microvolt T-Wave Alternans for Sudden Death Risk Stratification in Congestive Heart Failure (2006) (0)
OUTCOMES OF CARDIAC RESYNCHRONIZATION THERAPY IN ELDERLY PATIENTS WITH HEART FAILURE AND REDUCED LEFT VENTRICULAR EJECTION FRACTION: A META-ANALYSIS (2017) (0)
ARE THERE GENDER DIFFERENCES IN GUIDELINE-BASED STROKE PREVENTION MANAGEMENT AND OUTCOMES IN HIGH RISK ATRIAL FIBRILLATION PATIENTS PRESENTING TO AN ACADEMIC HOSPITAL? (2015) (0)
THE RISK OF STROKE INCREASES NEARLY THREE-FOLD AS PATIENTS WITH ATRIAL FIBRILLATION AGE FROM 66 TO 74 YEARS: A POPULATION-BASED COHORT STUDY (2020) (0)
THE ASSOCIATION OF HIGH-SENSITIVITY C-REACTIVE PROTEIN WITH RATES OF ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION (2022) (0)
Should prophylactic amiodarone therapy be used to prevent atrial tachyarrhythmia after cardiac surgery? (2006) (0)
Defibrillation Strategies for Refractory Ventricular Fibrillation. Reply. (2023) (0)
DISAGREEMENT BETWEEN PHYSICIAN-REPORTED AND SCORING SYSTEM-BASED STROKE AND BLEEDING RISKS IN PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE STROKE PREVENTION AND RHYTHM INTERVENTIONS IN ATRIAL FIBRILLATION (SPRINT-AF) REGISTRY (2014) (0)
ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS CURRENT STANDARD OF CARE REGIMEN IN A UNITED STATES NON-VALVULAR ATRIAL FIBRILLATION POPULATION SIMILAR TO THAT ENROLLED IN ARISTOTLE AND AVERROES (2014) (0)
DOES THE CARE OF PATIENTS WITH ATRIAL FIBRILLATION (AF) DIFFER BETWEEN AF AND GENERAL CARDIOLOGY CLINICS? EVALUATION OF PRACTICE PATTERN VARIATIONS WITH A CHECKLIST OF AMBULATORY AF CARE (2014) (0)
CANADIAN TRENDS IN UTILIZATION OF CARDIAC INTERVENTIONS FOLLOWING OUT-OF-HOSPITAL CARDIAC ARREST: EVIDENCE FOR SUBSTANTIAL UNDERUSE (2019) (0)
The Role of Bystander-initiated Basic Life Support in Sports-related Sudden Cardiac Arrest: A Systematic Review (2021) (0)
Chapter 19 – Ventricular Fibrillation (2005) (0)
Left atrial dimension is associated with atrial fibrillation recurrence: four-year echo follow-up data (2002) (0)
Reviewers for the Journal of Interventional Cardiac Electrophysiology 2013 (2014) (0)
ARE THERE DIFFERENCES IN ORAL ANTICOAGULANT THERAPIES IN HOSPITALIZED PATIENTS WITH ATRIAL FIBRILLATION AND MODERATE VERSUS SEVERE RENAL DYSFUNCTION? (2018) (0)
Challenges for the Basis of Practice Managing Patients with Rapid Atrial Fibrillation and Decompensated Heart Failure (2009) (0)
ARE BEST PRACTICE GUIDELINES INFORMING WITHDRAWAL OF LIFE SUSTAINING THERAPY FOLLOWED AFTER CARDIAC ARREST? (2022) (0)
TRAINING THE NEXT GENERATION OF CARDIOLOGISTS: ARE WE MEETING THEIR NEEDS? (2014) (0)
Abstract 233: The Relationship of Maximum Troponin Values Post Out-of-hospital Cardiac Arrest with Electrocardiographic Findings, Cardiac Procedures and Survival to Discharge; A Sub-study of ROC PRIMED (2013) (0)
171 The risk stratification and stroke prevention therapy care gap in canadian atrial fibrillation patients: Insights from the Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation (FREEDOM AF) knowledge translation program (2011) (0)
Abstract P72: Human Model for the Study of Cardio Pulmonary Resuscitation Using Wavelets (2008) (0)
The Family Study: Assessment of the Risk for Out-of-Hospital Cardiac Arrest in Family Members of Cardiac Arrest Patients (2013) (0)
ArrhythmiasAbstractsPlacebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter-defibrillator (2005) (0)
Psychological resolution of a supraventricular tachycardia. (1994) (0)
Response to Letter Regarding Article, “Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation: Results From the Resynchronization for Ambulatory Heart Failure Trial (RAFT)” (2013) (0)
P4625Association between pattern of atrial fibrillation and neurocognitive function in patients at low risk of stroke (2017) (0)
EP News: Quality Improvement and Outcomes: Defining and Measuring Atrial Fibrillation Quality Indicators in Canada (2021) (0)
Lifestyle modification for the management of atrial fibrillation (2020) (0)
Designing clinical trials in the post CAST era--where do we go from here? (1991) (0)
SUDDEN CARDIAC DEATH BY “HYPERTROPHIC CARDIOMYOPATHY WITH NO MYOFIBER DISARRAY” – A VARIANT OF HYPERTROPHIC CARDIOMYOPATHY OR A SEPARATE ENTITY? (2017) (0)
n-3 Polyunsaturated Fatty Acids Alter Expression of Fibrotic and Hypertrophic Genes in a Dog Model of Atrial Cardiomyopathy First (2009) (0)
What are patients reading? Assessing the quality of online resources on sudden cardiac arrest in athletes (2021) (0)
Prevention of Atrial Fibrillation: Is Amiodarone a First Choice? (2002) (0)
PERSISTENCE OF ORAL ANTICOAGULANT USE AMONG CANADIAN ATRIAL FIBRILLATION PATIENTS: ONE-YEAR RESULTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY (2018) (0)
Abstract 227: Sudden Cardiac Arrest During Exercise Occurs Infrequently and With Few Warning Symptoms (2019) (0)
Abstract 15954: Heterogeneity of Activation Rate Across LV Free Wall During Human VF and KATP Channel Expression Heterogeneity. (2010) (0)
Abstract 15178: Population-Based Evaluation of Appropriate Therapies and Death Among Elderly Implantable Cardioverter Defibrillator (ICD) Recipients: The Ontario ICD Database (2012) (0)
DOES PHYSIOLOGIC CARDIAC REMODELING IN ENDURANCE ATHLETES ALTER REPOLARIZATION OR QT DYNAMICS? (2019) (0)
PREDICTORS OF APPROPRIATE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) SHOCK AND DEATH: A COMPETING RISK ANALYSIS (2014) (0)
Abstract 15425: Is Accurate Stroke Risk ssessment with CHADS2 Necessary in Managing Patients with Atrial Fibrillation? Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry (2014) (0)
CAN GENDER INFLUENCE SYSTEM OF CARE, PATIENT SATISFACTION AND QUALITY OF LIFE FOR PATIENTS REFERRED TO THE ATRIAL FIBRILLATION CLINIC? (2014) (0)
Abstract 16503: Adequacy of Hypertension Control Among Patients With Atrial Fibrillation at High Cardiovascular Risk: Insights From a Canadian Prospective Registry (2017) (0)
Mechanical Ventilation in ARDS With an Automatic Resuscitator (2022) (0)
Obstructive sleep apnea is highly undetected in non-obese patients with atrial fibrillation (2017) (0)
Association of Diabetes Duration and Glycemic Control With Stroke Rate in Patients With Atrial Fibrillation and Diabetes: A Population‐Based Cohort Study (2022) (0)
P2618Association of left ventricular ejection fraction with mortality and hospitalizations (2019) (0)
Abstract 18393: Survival after Post-Arrest Therapeutic Hypothermia: Secondary Analysis of The Strategies for Post-Arrest Care (SPARC) Stepped-Wedge Trial (2011) (0)
Cardiac Arrest in Rabbits Effects of Rotigaptide , a Gap Junction Modifier , on Defibrillation Energy and Resuscitation From (2007) (0)
Abstract 12202: New York Heart Association Class and the Mortality Benefit From Primary Prevention Implantable Cardioverter Defibrillator Use: A Pooled Analysis of 4 Randomized Control Trials (2016) (0)
Abstract 19182: Sex Differences in Stroke Risk Profile, Stroke Prevention Therapy Use and Treatment Satisfaction in a Contemporary Cohort of Patients With Atrial Fibrillation: Insights From SPRINT-AF (2016) (0)
Metalodobenzylguanadine (MIBG) imaging or heart rate variability for assessment of diabetic cardiac autonomic dysfunction (1996) (0)
Electropharmacologic Control of Arrhythmias (1995) (0)
IDENTIFYING PUBLIC ACCESS DEFIBRILLATORS IN TORONTO: OPPORTUNITIES AND OBSTACLES (2020) (0)
THE EFFECT OF TIME TO TREATMENT WITH ANTIARRHYTHMIC DRUGS ON OUTCOMES IN SHOCK REFRACTORY OUT-OF-HOSPITAL CARDIAC ARREST: A SECONDARY ANALYSIS OF THE ALPS RANDOMIZED CONTROLLED TRIAL (2021) (0)
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality. (2023) (0)
FACTORS ASSOCIATED WITH CHANGES IN IMPAIRED QUALITY OF LIFE AMONG ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD CLINICAL PRACTICE: INSIGHTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY (2019) (0)
TREADMILL STRESS TEST VENTILATORY PATTERN USING A WEARABLE DEVICE AS AN ADDITIONAL MARKER FOR CV DISEASE (2022) (0)
Hot topics: arrhythmias (2011) (0)
Letter by Banks et al Regarding Article, "Does High-Intensity Endurance Training Increase the Risk of Atrial Fibrillation? A Longitudinal Study of Left Atrial Structure and Function". (2018) (0)
Three-dimensional bipolar voltage map demonstrating electrical activity of a single muscle bundle along the cavotricuspid isthmus. (2009) (0)
ISPOR 14th annual European congress research abstractPoster session II: Disease-specific studies: Cardiovascular disorders – cost studyPCV50 Hospital Costs Associated with Atrial Fibrillation in Canada (2011) (0)
P514Do atrial fibrillation patients with history of cerebrovascular accidents receive guideline-concordant stroke preventive therapies? Insights from the prospective SPRINT-AF registry (2017) (0)
Multi-centre implementation of an Educational program to improve the Cardiac Arrest diagnostic accuracy of ambulance Telecommunicators and survival outcomes for sudden cardiac arrest victims: the EduCATe study design and methodology (2021) (0)
Abstract 16025: The Association of Cardiology Billing Patterns With Healthcare Utilization and Clinical Outcomes in Atrial Fibrillation Patients (2020) (0)
P6-55: A prospective evaluation of various methods of assessing rate control in patients with permanent atrial fibrillation (2006) (0)
SAFETY OF RENAL SYMPATHETIC DENERVATION FOLLOWING RECENT MYOCARDIAL INFARCTION (2015) (0)
Quality of Life and Exercise Performance in Patients in Sinus Rhythm Versus Persistent Atrial Fibrillation A Cooperative Studies Program Substudy (2006) (0)
Policy and Promotion Canadian Cardiovascular Society Quality Indicators for Heart Failure Members of the Heart Failure Working Group (2016) (0)
Sport, Myocarditis, and Sudden Death: A Perfect Storm? (2022) (0)
Bedside right heart catheterization and invasive monitoring (2003) (0)
Refractory Angina Pectoris: A Therapeutic Challenge (2004) (0)
Identifying Patients for High Risk Primary Prevention The Role of Electron Beam CT Calcium Scoring (2002) (0)
IS THREE YEARS OF TRAINING SUFFICIENT TO DEVELOP A CARDIOVASCULAR SPECIALIST (2015) (0)
Estimating The Lifetime Clinical Risk/Benefits of Apixaban Versus Edoxaban In Non-Valvular Atrial Fibrillation (2015) (0)
A POPULATION-BASED COHORT STUDY OF A CLINICAL DECISION INSTRUMENT FOR 30-DAY DEATH FOLLOWING AN EMERGENCY DEPARTMENT VISIT FOR ATRIAL FIBRILLATION: THE ATRIAL FIBRILLATION IN THE EMERGENCY ROOM (AFTER) STUDY (2014) (0)
New Anticoagulants for Atrial Fibrillation: The Beginning of a A New Era in Stroke Prevention (2011) (0)
"Show me the money": the cost of atrial fibrillation. (2011) (0)
Development of a Technique for Short-Term Prediction of Hydrometeors Using Advection and Physical Forcing. (1983) (0)
CURATIVE RADIOFREQUENCY CATHETER ABLATION IN SUPRAVENTRICULAR TACHYCARDIA MANAGEMENT (1998) (0)
TEMPORAL TRENDS OF SUDDEN CARDIAC DEATH IN ONTARIO, CANADA FROM 2003-2013: THE IMPORTANCE OF PRIMARY AND SECONDARY CARDIAC PREVENTION (2018) (0)
Optimizing the Care of Pulmonary Arterial Hypertension: The Importance of Functional Class and the Specific Challenges of Eisenmenger Syndrome (2011) (0)
Understanding the Relationship Between Hypercholesterolemia and CKD - How is Kidney Disease Impacted by Dyslipidemia? (2011) (0)
PREDICTORS AND CLINICAL CONSEQUENCES OF INPATIENT VERSUS AMBULATORY MANAGEMENT AFTER AN INDEX EMERGENCY DEPARTMENT VISIT FOR ATRIAL FIBRILLATION: A POPULATION BASED STUDY (2015) (0)
Cell Therapy Following Acute Myocardial Infarction: Do Recent Clinical Trial Results Still Warrant Enthusiasm? (2006) (0)
Abstract 11817: The Effect of Time to Treatment With Antiarrhythmic Drugs on Return of Spontaneous Circulation in Shock Refractory Out-of-Hospital Cardiac Arrest: A Secondary Analysis of the ALPS Randomized Controlled Trial (2021) (0)
Epinephrine in Out-of-Hospital Cardiac Arrest - A Network Meta-Analysis and Subgroup Analyses of Shockable and Non-Shockable Rhythms. (2023) (0)
Sudden shortening of the paced AV delay: is this normal pacemaker function? (2015) (0)
Review of atrial fibrillation and the lessons of 30 years AtRiAl FibRillA tion - 30 yeARs on (2015) (0)
Out-of-Hospital Cardiac Arrest in the Presence of Ischemic Heart Disease: What Is the Long-term Arrhythmic Risk After Revascularization? (2018) (0)
Abstract 18556: Renal Sympathetic Denervation Modulates Cardiac Repolarization in a Post Myocardial Infarction Pig Model (2015) (0)
ARE THERE GENDER-RELATED DIFFERENCES IN PRESENTATION AND MANAGEMENT OF HIGH RISK HOSPITALIZED PATIENTS PRESENTING TO AN ACADEMIC HOSPITAL WITH ATRIAL FIBRILLATION? (2017) (0)
Endothelial Shear Stress: Impact on Atherosclerosis (2007) (0)
PL02: Double Sequential External Defibrillation for Refractory Ventricular Fibrillation: the DOSE VF pilot randomized controlled trial (2020) (0)
Atrial Fibrillation Maintenance of Sinus Rhythm and Survival in Patients With Heart Failure and (2012) (0)
Does cardiovascular preparticipation screening cause psychological distress in athletes? A systematic review (2022) (0)
Abstract 3501: Azimilide Reduces Arrhythmic-Related ER visits and Hospitalizations in Patients with an ICD: Results from the SHIELD trial (2006) (0)
Cardiovascular syndromes associated with cocaine use (2003) (0)
Post Arrest Consult Team: a knowledge translation strategy for post-cardiac arrest care (2014) (0)
Abstract 152: Intrinsic Vascular Tone may be Necessary for Successful Resuscitation from Experimental Cardiac Arrest (2013) (0)
Training/Practice Contemporary Issues in Cardiology Practice Applying the Atrial Fibrillation Guidelines Update to Manage Your Patients With Atrial Fibrillation (2014) (0)
Strategies for improving post arrest care: The S.P.A.R.C. hypothermia project (2008) (0)
Carcinoid heart disease: The heart is part of the whole body (2002) (0)
Prevention of radiocontrast-induced nephropathy (2003) (0)
Therapeutic Hypothermia in Post-Cardiac Arrest Patients : Study Protocol for a Stepped Wedge Cluster Randomized Trial (2011) (0)
Do Permanent Pacemakers Need an Insulative Coating? Results of a Prospective Randomized Double‐Blind Study (1997) (0)
Myocardial strain assessment using cardiovascular magnetic resonance imaging in recipients of implantable cardioverter defibrillators (2021) (0)
Abstract 259: Identifying Predictors of Cumulative Health Care Costs in Incident Atrial Fibrillation: a Population-Based Study (2014) (0)
Exaggerated Blood Pressure Responses To Exercise: Assessment Of Criteria In Middle-aged Male Endurance Athletes (2021) (0)
Flecainide and elevated liver enzymes in α1-antitrypsin deficiency (2016) (0)
Abstract 241: Pre- and Postshock Electrogram Features in Human VF and the Occurrence of Refibrillation (2011) (0)
The association of stroke rate with low density lipoprotein and statin exposure in patients with atrial fibrillation (AF) (2021) (0)
Adenosine is superior to carotid sinus massage in the diagnosis of sinus node disease (1996) (0)
Cardiac Arrest: Antiarrhythmic therapy during cardiac arrest and resuscitation (2007) (0)
Federal leadership needed to realize national data set for cardiovascular care (2017) (0)
THE INFLUENCE OF STROKE AND BLEEDING RISK ON ORAL ANTICOAGULATION USE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE STROKE PREVENTION AND RHYTHM INTERVENTIONS IN ATRIAL FIBRILLATION (SPRINT-AF) REGISTRY (2014) (0)
P4-58: Cardiac electrophysiological consequences of stun gun discharge vector in an experimental model (2006) (0)
Abstract 237: Do We Treat Women Differently? Health Care Providers' Perspectives on Gender Differences in Post-arrest Care (2013) (0)
DEPRESSION IS ASSOCIATED WITH HIGHER MORTALITY IN PATIENTS WITH A HISTORY OF VENTRICULAR FIBRILLATION/TACHYCARDIA (1999) (0)
HIV and the heart (2000) (0)
PROLONGED P WAVE DURATION IS NOT ASSOCIATED WITH SUBCLINICAL ATRIAL ARRHYTHMIAS IN MIDDLE-AGED ENDURANCE ATHLETES (2015) (0)
Sudden shortening of the paced AV delay: is this normal pacemaker function? (2015) (0)
Abstract 292: Time Course of Epinephrine Administration During Cardiac Arrest Shows Transient Increase in Aortic Pressure at the Cost of Persistent Decrease in Carotid Flow (2013) (0)
A CLINICAL DECISION INSTRUMENT TO PREDICT 30-DAY DEATH AND SUBSESQUENT CARDIOVASCULAR HOSPITALIZATIONS FOLLOWING AN EMERGENCY DEPARTMENT VISIT FOR ATRIAL FIBRILLATION: THE ATRIAL FIBRILLATION IN THE EMERGENCY ROOM (AFTER) STUDY, PART 2 (2015) (0)
Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis (2022) (0)
Fabry's Cardiomyopathy: Diagnosis, Pathophysiology and the Role of Enzyme Replacement Therapy (2007) (0)
Wearables for cardiac monitoring in athletes: precious metal or fool’s gold? (2021) (0)
ECG COMPUTER INTERPRETATION AND CARDIOLOGY TRAINEES: HELP OR HINDERANCE? (2016) (0)
The emerging role of cardiovascular MRI in the evaluation of cardiovascular disorders (2002) (0)
Abstract 2438: Complications Increase Mortality Risk After De Novo Implantion of a Cardioverter Defibrillator: Initial Findings From the Ontario ICD Database (2009) (0)
DINAMIT: Does ICD Implantation Improve Life Expectancy in Survivors of Acute Myocardial Infarction? (2000) (0)
Lipid Lowering Therapy in Primary and Secondary Prevention: Insights from LIPID and WOSCOPS (1997) (0)
A Report Using a Hybrid ICD System: The Need for Compatibility Among Implanted Defibrillator Components (1994) (0)
Response by Weissler-Snir and Dorian to Letter Regarding Article, "Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario". (2020) (0)
PATTERNS OF ANTITHROMBOTIC USE IN RELATION TO THE CHA2DS2-VASC AND THE CHADS2-65 STROKE RISK SCORE IN CONTEMPORARY PRACTICE: INSIGHTS FROM A PROSPECTIVE CANADIAN AF REGISTRY (2016) (0)
Association of Cardiology Billing Amounts With Health Care Utilization and Clinical Outcomes in Patients With Atrial Fibrillation (2021) (0)
Restoring sinus rhythm in atrial fibrillation*Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. (2003) (0)
FACTORS ASSOCIATED WITH IMPAIRED QUALITY OF LIFE AMONG ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD CLINICAL PRACTICE: INSIGHTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY (2018) (0)
815 Predictors of 90-Day Death Following an Emergency Department Visit for Atrial Fibrillation (2012) (0)
PATIENT SPECIFIC REASONS FOR ATTENDING THE EMERGENCY DEPARTMENT IN THE SETTING OF ATRIAL FIBRILLATION (2017) (0)
WHAT FACTORS INFLUENCE THE CHOICE OF APIXABAN, RIVAROXABAN, OR DABIGATRAN FOR STROKE PREVENTION AMONG ATRIAL FIBRILLATION PATIENTS IN REAL-WORLD CLINICAL PRACTICE? INSIGHTS FROM THE PROSPECTIVE SPRINT-AF REGISTRY (2018) (0)
TRANSITIONING EMERGENCY ATRIAL FIBRILLATION MANAGEMENT (TEAM) MODEL IMPROVES QUALITY OF LIFE AND HELPS PATIENTS AVOID ED VISITS (2015) (0)
THE ASSOCIATION OF DIABETES DURATION AND GLYCEMIC CONTROL WITH STROKE IN PATIENTS WITH ATRIAL FIBRILLATION AND DIABETES (2021) (0)
ESTIMATING THE LIFETIME CLINICAL BENEFITS OF APIXABAN VERSUS ASPIRIN IN THE LOW RISK NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN THE US: HOW MAY RESULTS FROM AVERROES HELP IMPROVE PATIENT CARE? (2015) (0)
Health-Related Quality of Life in Patients With Atrial Fibrillation Treated With Rhythm Control Versus Rate Control (2014) (0)
The Effect of Time to Treatment With Antiarrhythmic Drugs on Survival and Neurological Outcomes in Shock Refractory Out-of-Hospital Cardiac Arrest (2023) (0)
Wednesday, 29 August 2012 (2012) (0)
therapy from atrial fibrillation and sinus tachycardia in automated implantable cardioverter defibrillators (2000) (0)
LOW CARDIOVASCULAR HEALTHCARE UTILIZATION PRIOR TO OUT OF HOSPITAL CARDIAC ARREST: A CANADA WIDE ANALYSIS (2021) (0)
Recent studies have proven that an option of pharmacologic and non-pharmacologic therapy is available to patients who suffer from AF. Atrial Fibrillation (2003) (0)
Torsades de pointes ventricular tachycardia following right pneumonectomy: insights into the relation between right cardiac (1994) (0)
COMPETENCY-BASED EDUCATION IN CARDIOLOGY: IS IT TIME? (2014) (0)
Mechanical Ventilation of Lung Injury with an Automatic Resuscitator: Randomized Controlled Experimental Study Using an ARDS Model (2022) (0)
MP022: Anticoagulation use in patients with atrial fibrillation/flutter in Canadian emergency departments since the introduction of the novel anticoagulants (2016) (0)
Abstract 2848: Predictive Factors for Therapeutic Success in Patients With Recent-onset Paroxysmal and Persistent Atrial Fibrillation in the RecordAF Registry (2009) (0)
Clinical Trials on Atrial Fibrillation/Future Perspectives (2011) (0)
Clinical Research The Risk Stratification and Stroke Prevention Therapy Care Gap in Canadian Atrial Fibrillation Patients (2016) (0)
PHYSIOLOGIC CARDIAC REMODELING IN MIDDLE-AGED ATHLETES IS INDEPENDENT OF ENDURANCE SPORT DISCIPLINE: A CARDIAC MAGNETIC RESONANCE STUDY (2019) (0)
Editorial Commentary: Whither antiarrhythmic drug therapy? (2016) (0)
An Association Between Cardiologist Billing Patterns, Health Care Use, and Outcomes in Cardiac Patients (2021) (0)
Treatment of obstructive sleep apnea decreases the recurrence of atrial and ventricular ectopy in patients with atrial fibrillation (2017) (0)
Multicenter clinical investigation of a second generation programmable pacemaker-cardioverter-defibrillator (1991) (0)
INFLUENCE OF CHRONIC KIDNEY DISEASE ON THE EFFICACY OF PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER DEFIBRILLATORS: A META-ANALYSIS OF THREE RANDOMIZED TRIALS (2013) (0)
A NOVEL ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY (ARVC) BIOMARKER ANTI-DSG2 IS ABSENT IN ATHLETES WITH RIGHT VENTRICULAR ENLARGEMENT (2019) (0)
Abstract 1738: Lone Atrial Fibrillation: Long-Term Clinical and Echocardiographic Follow-up from the Canadian Registry of Atrial Fibrillation (2007) (0)
Abstract 20190: Sudden Cardiac Death in the Young is Frequently Associated With Cardiac Disease and Drug Use (2014) (0)
305 N-3 Polyunsaturated fatty acids alter expression of fibrotic and hypertrophic genes in a dog model of atrial cardiomyopathy (2010) (0)
Abstract 18609: Cost-effectiveness of Apixaban Against Dabigatran and Rivaroxaban for Stroke Prevention in Non-valvular Atrial Fibrillation Patients (2014) (0)
INCIDENCE RATE, CIRCUMSTANCES, AND CARDIAC SYMPTOMS PRECEDING SUDDEN CARDIAC DEATH CAUSED BY HYPERTROPHIC CARDIOMYOPATHY (2017) (0)
The emerging role of angiotensin receptor blockers in the therapy of chronic heart failure (2001) (0)
Atrial Fibrillation. (2021) (0)
Abstract 34: The Effects of an Automatic Low Pressure Ventilation Device versus Manual Ventilation During Cardiopulmonary Resuscitation in a Porcine Model of Cardiac Arrest (2006) (0)
P3612Antithrombotic use amongst patients at low stroke risk as defined by the CHA2DS2-VASc score: Insight from the prospective SPRINT-AF registry (2017) (0)
Unfiltered QRS duration predicts the presence of late potentials on the signal averaged ECG (1991) (0)
YOUR COMPLETE GUIDE TO ATRIAL FIBRILLATION: IMPLEMENTATION OF CANADIAN CARDIOVASCULAR SOCIETY/HEART AND STROKE FOUNDATION OF CANADA PATIENT EDUCATION RESOURCES (2014) (0)
Applying the new STEMI guidelines: 2. Disturbances of cardiac rhythm after ST-segment elevation myocardial infarction (2004) (0)
Beyond the medals: a cross-sectional study exploring retired elite female athletes’ health (2023) (0)
674 The potential clinical impact of cardiovascular magnetic resonance on eligibility for implantable cardioverter defibrillators (2011) (0)
Implementing a System of Care for Atrial Fibrillation in the Emergency Room Leads to Patient Satisfaction and Improved Quality of Life (2013) (0)
Non-ST Segment Elevation Myocardial Infarction: Risk Stratification and Early Management (2006) (0)
[Standards for the practice of cardiac electrophysiology in adults. Subcommittee on Electrophysiology. Committee on Standards of the Canadian Society of Cardiology]. (1996) (0)
PROVISION OF EMERGENCY DEPARTMENT PRESCRIPTIONS FOR ORAL ANTICOAGULATION AND SUBSEQUENT LONG-TERM USE IN PATIENTS WITH ATRIAL FIBRILLATION (2019) (0)
556 How competent are cardiology residents in interpreting ECGS? A controlled trial using an analytic framework (2011) (0)
Abstract P71: The Benefits of a Simplified Method for CPR Training of Medical Professionals: A Randomized Controlled Study (2009) (0)
Abstract 351: The Family Study: Assessment of the Risk for Sudden Cardiac Arrest in Family Members of Cardiac Arrest Patients (2013) (0)
REGIONAL REGULATION OF BLOOD FLOW PREDICTS SURVIVAL IN EXPERIMENTAL CARDIAC ARREST (2014) (0)
Dantrolene Decreases Susceptibility to Refibrillations by Restoring VF-Dependent Cardiac Calcium Handling Dysfunction (2013) (0)
Abstract 15439: High Rates of antiplatelet Use in Atrial Fibrillation Patients Treated With Oral Anticoagulation: Insights from the Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry (2014) (0)
642 Failed defibrillation testing among patients having ICD replacement: Incidence, predictors and influence of selection BIAS (2011) (0)
COMPARISON OF CARDIAC MRI AND RADIONUCLIDE VENTRICULOGRAPHY FOR MEASUREMENT OF LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS BEING CONSIDERED FOR PRIMARY PROPHYLACTIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (2015) (0)
Advancing Stroke Prevention in Atrial Fibrillation: The Emerging Role of Factor Xa Inhibition (2011) (0)
RENAL SYMPATHETIC DENERVATION FOLLOWING MYOCARDIAL INFARCTION AND ITS SUBSEQUENT CARDIAC ELECTROPHYSIOLOGICAL EFFECTS (2015) (0)
Abstract 20231: Effect of Coronary Ischemic Burden on Therapies for Ventricular Tachyarrhythmia (VT) and Death in Patients with an Implantable Cardioverter Defibrillator (ICD) (2010) (0)
Abstract 149: Double Sequential External Defibrillation in Refractory Ventricular Fibrillation: The Dose VF Pilot Randomized Controlled Trial (2019) (0)
Abstract 18178: Cause-Specific Mortality in Patients with Prior Anterior Myocardial Infarction: Clinical Predictors Identified in the Home Automated External Defibrillator Trial (2010) (0)
The Canadian registry of atrial fibrillation: Lack of prognostic differences between atrial fibrillation and atrial flutter (2003) (0)
621 Developing an In-Vivo Model of Ventricular Re-Fibrillation (2012) (0)
STROKE PREVENTION IN ATRIAL FIBRILLATION PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT: ARE PREVIOUSLY DIAGNOSED PATIENTS UNDERTREATED? (2016) (0)
“WHY WARM UP?”: EXERCISE ONSET AND THE EARLY PEAK IN PULMONARY ARTERY WEDGE PRESSURE IN HEALTHY OLDER ADULTS (2018) (0)
An In-Silico model for evaluating the directional shock vectors in terminating and modulating rotors (2022) (0)
Effects of Mg++ on ischemic and reperfusion arrhythmias (1986) (0)
“It’s Overwhelming With the Grief” A Qualitative Study of Families’ Experiences When a Young Relative Dies of Sudden Cardiac Death (2023) (0)
Abstract 335: Distinguishing Cardiac From Non-Cardiac Causes of Sudden Death: The Value of Novel Factors to Identify Risk of SCD (2018) (0)
Sensitivity to Antiplatelet Agents in Patients with Acute Coronary Syndromes: Role of Desensitization Therapy (2006) (0)
SAFETY AND EFFICACY OF NON-VITAMIN K ORAL ANTICOAGULANTS (NOAC) VERSUS WARFARIN ACROSS VARIOUS TIME IN THERAPEUTIC RANGE (TTR) STRATA AMONG PATIENTS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS (2018) (0)
Letter by McEvoy Regarding Article, "Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both" (2011) (0)
Abstract 4095: Maintenance of Sinus Rhythm Is Not Associated with Improved Survival in Patients with Atrial Fibrillation and Heart Failure (2008) (0)
FEMALE SEX IS NOT ASSOCIATED WITH INCREASED SURVIVAL AFTER NON-TRAUMATIC OUT OF HOSPITAL CARDIAC ARREST: A SYSTEMATIC REVIEW AND META-ANALYSIS (2022) (0)
PATIENT PERCEPTIONS AFTER EMERGENCY DEPARTMENT VISITS FOR ATRIAL FIBRILLATION: UNNECESSARY FEAR? (2022) (0)
Abstract 3497: N-3 Polyunsaturated Fatty Acids Alter Gene Expression Profile and Reduce Vulnerability to Atrial Fibrillation in a Dog Model of Cardiomyopathy (2008) (0)
Abstract 166: Hospital Experience with Post Out-of-Hospital Cardiac Arrest Patients Is Associated with Successful Targeted Temperature Management (2014) (0)
MP09: Canadian Community Utilization of Stroke Prevention Pilot Study-Emergency Department (C-CUSP ED) (2017) (0)
384 Challenges in the management of atrial fibrillation: Results from a national educational needs assessment (2011) (0)
Sotalol is safe and effective in preventing frequent shocks delivered to patients with implantable cardioverter-defibrillators (1999) (0)
Use of Apixaban and Warfarin in Patients Undergoing Procedures: Insights from ARISTOTLE (P5.002) (2014) (0)
Advances in Antiarrhythmic Drug Therapy: New and Emerging Therapies. (2010) (0)
Abstract 1259: Polyunsaturated Fatty Acids Reduce Inducible Atrial Fibrillation in a New Canine Pacing Model (2006) (0)
ICD IMPLANTATION RATES AFTER CARDIAC ARREST WITH SURVIVAL TO DISCHARGE: ARE THE RATES GUIDELINE CONCORDANT? (2015) (0)
Patterns of implantable cardioverter defibrillator use in Canada (1992) (0)
CURRENT DEFINITIONS TO IDENTIFY SUDDEN CARDIAC DEATH AS A CAUSE FOR CARDIAC ARREST ARE INACCURATE: LIMITATIONS OF EMS RECORDS (2022) (0)
Abstract 2620: n-3 Polyunsaturated Fatty Acid Prophylaxis Reduces Vulnerability to Atrial Fibrillation in a Dog Model of Cardiomyopathy (2009) (0)
Abstract 222: Does Gender Matter for Postarrest Care? (2012) (0)
Early Return Ed Visits for Atrial Fibrillation Are Common: Can They Be Predicted? (2013) (0)
Ultrafiltration in Acute Decompensated Heart Failure (2007) (0)
The effects of long chain polyunsaturated fatty acids on local activation properties in dogs vulnerable to atrial fibrillation (2014) (0)
Abstract 18984: Discrepancy Between Originally Assigned and Adjudicated Causes of Out-of-Hospital-Cardiac-Arrest of “No Obvious Cause” in Young Patients (2014) (0)
TRIPLE VERSUS DUAL ANTITHROMBOTIC THERAPY FOR PATIENTS WHO REQUIRE ORAL ANTICOAGULATION AND UNDERGO PERCUTANEOUS CORONARY INTERVENTION: AN UPDATED META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2019) (0)
Abstract 13142: The Atrial Fibrillation Effect on Quality-of-Life Study: A New, Validated, and Comprehensive Quality-of-Life Tool for Atrial Fibrillation (AF) (2010) (0)
The combined use of diagnosed mesoscale frontogenesis and satellite imagery in forecasting squall line formation (1987) (0)
Abstract 230: Targeted Temperature Management: Exploring the Association Between Processes of Care and Outcomes After Out-of-Hospital Cardiac Arrest (2013) (0)
CARDIAC RHYTHM DEVICE PROCEDURE RELATED COMPLICATIONS - TRACKING AND NEED FOR CONTINUOUS QUALITY IMPROVEMENT PROGRAMS (2014) (0)
Geosurface radiometric temperatures from atmospherically corrected multi-angle measurements (1993) (0)
Chapter 31 – Arrhythmias in the Critical Care Setting (2006) (0)
COMPARISON OF HEALTH RELATED QUALITY OF LIFE IN ATRIAL FIBRILLATION PATIENTS TREATED WITH CATHETER ABLATION OR ANTIARRHYTHMIC DRUG THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS (2017) (0)
THE ASSOCIATION OF QUANTITATIVE AND SEMI-QUANTITATIVE PROTEINURIA WITH ADVERSE OUTCOMES IN ATRIAL FIBRILLATION (2022) (0)
Abstract 10437: Epinephrine in Cardiac Arrest: A Randomized, Multicenter, Double-blinded, Placebo-Controlled Experimental Trial (2015) (0)
COMPARATIVE PROGNOSTIC SIGNIFICANCE OF DIFFERENT METHODS OF SCAR QUANTIFICATION IN PATIENTS RECEIVING IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (2020) (0)
Adenosine for Maternal Supraventricular Tachycardia and Preterm Delivery (2011) (0)
Subject Index, Vol. 27 (Suppl 2), 1983 (1983) (0)
LO67: The impact of CPR quality during entire resuscitation episode on survival from cardiac arrest (2017) (0)
Docosahexaenoic Acid, But Not Eicosapentaenoic Acid, Supplementation (2017) (0)

This paper list is powered by the following services:

Other Resources About Paul Dorian

en.wikipedia.org

What Schools Are Affiliated With Paul Dorian?

Paul Dorian is affiliated with the following schools:

Paul Dorian's Academic­Influence.com Rankings

Paul Dorian's Degrees

Why Is Paul Dorian Influential?

Paul Dorian's Published Works

Published Works

Other Resources About Paul Dorian

What Schools Are Affiliated With Paul Dorian?

Paul Dorian's AcademicInfluence.com Rankings